Richtlijn HIV
Deze pagina is het laatst bewerkt op 28 apr 2021 om 12:32. | Deze pagina is 35.792 maal bekeken.

Lijst met verwijzingen naar andere richtlijnen

Uit Richtlijnen HIV

(Verschil tussen bewerkingen)
Ga naar: navigatie, zoeken
Regel 1: Regel 1:
In onderstaande tabel staan verwijzingen naar andere richtlijnen opgesomd:  
In onderstaande tabel staan verwijzingen naar andere richtlijnen opgesomd:  
-
<br><div class="WordSection1">
+
 
-
{| cellspacing="0" cellpadding="0" border="1" style="mso-yfti-irow:0;mso-yfti-firstrow:yes" class="MsoTableGrid"
+
 
 +
 
 +
{| cellspacing="0" cellpadding="0" border="1" class="MsoTableGrid" style="mso-yfti-irow:0;mso-yfti-firstrow:yes"
|-
|-
| width="350" valign="top" style="width:262.5pt;border:solid windowtext 1.0pt; mso-border-alt:solid windowtext .5pt;padding:0cm 5.4pt 0cm 5.4pt" |  
| width="350" valign="top" style="width:262.5pt;border:solid windowtext 1.0pt; mso-border-alt:solid windowtext .5pt;padding:0cm 5.4pt 0cm 5.4pt" |  
-
'''Pagina&lt;o:p&gt;&lt;/o:p&gt;'''
+
'''Pagina'''  
| width="269" valign="top" style="width:201.9pt;border:solid windowtext 1.0pt; border-left:none;mso-border-left-alt:solid windowtext .5pt;mso-border-alt: solid windowtext .5pt;padding:0cm 5.4pt 0cm 5.4pt" |  
| width="269" valign="top" style="width:201.9pt;border:solid windowtext 1.0pt; border-left:none;mso-border-left-alt:solid windowtext .5pt;mso-border-alt: solid windowtext .5pt;padding:0cm 5.4pt 0cm 5.4pt" |  
-
'''Verwijzing naar andere richtlijnen&lt;o:p&gt;&lt;/o:p&gt;'''
+
'''Verwijzing naar andere richtlijnen&lt;o:p&gt;&lt;/o:p&gt;'''  
|- style="mso-yfti-irow:1"
|- style="mso-yfti-irow:1"
| width="350" valign="top" style="width:262.5pt;border:solid windowtext 1.0pt; border-top:none;mso-border-top-alt:solid windowtext .5pt;mso-border-alt:solid windowtext .5pt; padding:0cm 5.4pt 0cm 5.4pt" |  
| width="350" valign="top" style="width:262.5pt;border:solid windowtext 1.0pt; border-top:none;mso-border-top-alt:solid windowtext .5pt;mso-border-alt:solid windowtext .5pt; padding:0cm 5.4pt 0cm 5.4pt" |  
-
'''&lt;a'''
+
'''&lt;a'''  
-
'''href="http://www.nvhb.nl/richtlijnhiv/extensions/FCKeditor/fckeditor/editor/Richtlijn%20HIV"&gt;Hoofdpagina'''
+
'''href="http://www.nvhb.nl/richtlijnhiv/extensions/FCKeditor/fckeditor/editor/Richtlijn%20HIV"&gt;Hoofdpagina''' '''(=inhoudsopgave)&lt;/a&gt;&lt;o:p&gt;&lt;/o:p&gt;'''  
-
'''(=inhoudsopgave)&lt;/a&gt;&lt;o:p&gt;&lt;/o:p&gt;'''
+
 +
<br>
| width="269" valign="top" style="width:201.9pt;border-top:none;border-left: none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt; mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid windowtext .5pt; mso-border-alt:solid windowtext .5pt;padding:0cm 5.4pt 0cm 5.4pt" |  
| width="269" valign="top" style="width:201.9pt;border-top:none;border-left: none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt; mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid windowtext .5pt; mso-border-alt:solid windowtext .5pt;padding:0cm 5.4pt 0cm 5.4pt" |  
-
<span style="mso-bidi-font-weight:bold">&lt;o:p&gt;&nbsp;&lt;/o:p&gt;</span>
+
<span style="mso-bidi-font-weight:bold">&lt;o:p&gt;&nbsp;&lt;/o:p&gt;</span>  
|- style="mso-yfti-irow:2"
|- style="mso-yfti-irow:2"
| width="350" valign="top" style="width:262.5pt;border:solid windowtext 1.0pt; border-top:none;mso-border-top-alt:solid windowtext .5pt;mso-border-alt:solid windowtext .5pt; padding:0cm 5.4pt 0cm 5.4pt" |  
| width="350" valign="top" style="width:262.5pt;border:solid windowtext 1.0pt; border-top:none;mso-border-top-alt:solid windowtext .5pt;mso-border-alt:solid windowtext .5pt; padding:0cm 5.4pt 0cm 5.4pt" |  
-
'''&lt;o:p&gt;&nbsp;&lt;/o:p&gt;'''
+
'''&lt;o:p&gt;&nbsp;&lt;/o:p&gt;'''  
| width="269" valign="top" style="width:201.9pt;border-top:none;border-left: none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt; mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid windowtext .5pt; mso-border-alt:solid windowtext .5pt;padding:0cm 5.4pt 0cm 5.4pt" |  
| width="269" valign="top" style="width:201.9pt;border-top:none;border-left: none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt; mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid windowtext .5pt; mso-border-alt:solid windowtext .5pt;padding:0cm 5.4pt 0cm 5.4pt" |  
-
<span style="mso-bidi-font-weight:bold">&lt;o:p&gt;&nbsp;&lt;/o:p&gt;</span>
+
<span style="mso-bidi-font-weight:bold">&lt;o:p&gt;&nbsp;&lt;/o:p&gt;</span>  
|- style="mso-yfti-irow:3"
|- style="mso-yfti-irow:3"
| width="350" valign="top" style="width:262.5pt;border:solid windowtext 1.0pt; border-top:none;mso-border-top-alt:solid windowtext .5pt;mso-border-alt:solid windowtext .5pt; padding:0cm 5.4pt 0cm 5.4pt" |  
| width="350" valign="top" style="width:262.5pt;border:solid windowtext 1.0pt; border-top:none;mso-border-top-alt:solid windowtext .5pt;mso-border-alt:solid windowtext .5pt; padding:0cm 5.4pt 0cm 5.4pt" |  
-
'''&lt;a'''
+
'''&lt;a'''  
-
'''href="http://www.nvhb.nl/richtlijnhiv/extensions/FCKeditor/fckeditor/editor/Hoofdstuk%201.%20Achtergrondinformatie%20bij%20de%20ontwikkeling%20en%20herziening%20van%20deze%20richtlijn%20en%20inleiding"&gt;Hoofdstuk 1. Achtergrondinformatie bij de ontwikkeling en herziening van deze richtlijn'''
+
'''href="http://www.nvhb.nl/richtlijnhiv/extensions/FCKeditor/fckeditor/editor/Hoofdstuk%201.%20Achtergrondinformatie%20bij%20de%20ontwikkeling%20en%20herziening%20van%20deze%20richtlijn%20en%20inleiding"&gt;Hoofdstuk 1. Achtergrondinformatie bij de ontwikkeling en herziening van deze richtlijn''' '''en inleiding&lt;/a&gt;&lt;o:p&gt;&lt;/o:p&gt;'''  
-
'''en inleiding&lt;/a&gt;&lt;o:p&gt;&lt;/o:p&gt;'''
+
 +
<br>
| width="269" valign="top" style="width:201.9pt;border-top:none;border-left: none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt; mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid windowtext .5pt; mso-border-alt:solid windowtext .5pt;padding:0cm 5.4pt 0cm 5.4pt" |  
| width="269" valign="top" style="width:201.9pt;border-top:none;border-left: none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt; mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid windowtext .5pt; mso-border-alt:solid windowtext .5pt;padding:0cm 5.4pt 0cm 5.4pt" |  
-
<span style="mso-bidi-font-weight:bold">NVHB Richtlijn 2007&lt;o:p&gt;&lt;/o:p&gt;</span>
+
<span style="mso-bidi-font-weight:bold">NVHB Richtlijn 2007&lt;o:p&gt;&lt;/o:p&gt;</span>  
|- style="mso-yfti-irow:4"
|- style="mso-yfti-irow:4"
Regel 42: Regel 44:
&lt;a  
&lt;a  
-
href="http://www.nvhb.nl/richtlijnhiv/extensions/FCKeditor/fckeditor/editor/Procedure%20herziening"&gt;Procedure  
+
href="http://www.nvhb.nl/richtlijnhiv/extensions/FCKeditor/fckeditor/editor/Procedure%20herziening"&gt;Procedure herziening&lt;/a&gt;  
-
herziening&lt;/a&gt;
+
 +
<br>
| width="269" valign="top" style="width:201.9pt;border-top:none;border-left: none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt; mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid windowtext .5pt; mso-border-alt:solid windowtext .5pt;padding:0cm 5.4pt 0cm 5.4pt" |  
| width="269" valign="top" style="width:201.9pt;border-top:none;border-left: none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt; mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid windowtext .5pt; mso-border-alt:solid windowtext .5pt;padding:0cm 5.4pt 0cm 5.4pt" |  
-
NVHB Richtlijn 2007
+
NVHB Richtlijn 2007  
|- style="mso-yfti-irow:5"
|- style="mso-yfti-irow:5"
Regel 53: Regel 55:
&lt;a  
&lt;a  
-
href="http://www.nvhb.nl/richtlijnhiv/extensions/FCKeditor/fckeditor/editor/Samenstelling%20kernwerkgroep"&gt;Samenstelling  
+
href="http://www.nvhb.nl/richtlijnhiv/extensions/FCKeditor/fckeditor/editor/Samenstelling%20kernwerkgroep"&gt;Samenstelling kernwerkgroep&lt;/a&gt;  
-
kernwerkgroep&lt;/a&gt;
+
 +
<br>
| width="269" valign="top" style="width:201.9pt;border-top:none;border-left: none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt; mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid windowtext .5pt; mso-border-alt:solid windowtext .5pt;padding:0cm 5.4pt 0cm 5.4pt" |  
| width="269" valign="top" style="width:201.9pt;border-top:none;border-left: none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt; mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid windowtext .5pt; mso-border-alt:solid windowtext .5pt;padding:0cm 5.4pt 0cm 5.4pt" |  
-
&lt;o:p&gt;&nbsp;&lt;/o:p&gt;
+
&lt;o:p&gt;&nbsp;&lt;/o:p&gt;  
|- style="mso-yfti-irow:6"
|- style="mso-yfti-irow:6"
Regel 64: Regel 66:
&lt;a  
&lt;a  
-
href="http://www.nvhb.nl/richtlijnhiv/extensions/FCKeditor/fckeditor/editor/Overzicht%20belangen%20werkgroepleden"&gt;Overzicht  
+
href="http://www.nvhb.nl/richtlijnhiv/extensions/FCKeditor/fckeditor/editor/Overzicht%20belangen%20werkgroepleden"&gt;Overzicht belangen werkgroepleden&lt;/a&gt;  
-
belangen werkgroepleden&lt;/a&gt;
+
 +
<br>
| width="269" valign="top" style="width:201.9pt;border-top:none;border-left: none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt; mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid windowtext .5pt; mso-border-alt:solid windowtext .5pt;padding:0cm 5.4pt 0cm 5.4pt" |  
| width="269" valign="top" style="width:201.9pt;border-top:none;border-left: none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt; mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid windowtext .5pt; mso-border-alt:solid windowtext .5pt;padding:0cm 5.4pt 0cm 5.4pt" |  
-
&lt;o:p&gt;&nbsp;&lt;/o:p&gt;
+
&lt;o:p&gt;&nbsp;&lt;/o:p&gt;  
|- style="mso-yfti-irow:7"
|- style="mso-yfti-irow:7"
| width="350" valign="top" style="width:262.5pt;border:solid windowtext 1.0pt; border-top:none;mso-border-top-alt:solid windowtext .5pt;mso-border-alt:solid windowtext .5pt; padding:0cm 5.4pt 0cm 5.4pt" |  
| width="350" valign="top" style="width:262.5pt;border:solid windowtext 1.0pt; border-top:none;mso-border-top-alt:solid windowtext .5pt;mso-border-alt:solid windowtext .5pt; padding:0cm 5.4pt 0cm 5.4pt" |  
-
&lt;a href="http://www.nvhb.nl/richtlijnhiv/extensions/FCKeditor/fckeditor/editor/Definities"&gt;Definities&lt;/a&gt;
+
&lt;a href="http://www.nvhb.nl/richtlijnhiv/extensions/FCKeditor/fckeditor/editor/Definities"&gt;Definities&lt;/a&gt;  
| width="269" valign="top" style="width:201.9pt;border-top:none;border-left: none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt; mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid windowtext .5pt; mso-border-alt:solid windowtext .5pt;padding:0cm 5.4pt 0cm 5.4pt" |  
| width="269" valign="top" style="width:201.9pt;border-top:none;border-left: none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt; mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid windowtext .5pt; mso-border-alt:solid windowtext .5pt;padding:0cm 5.4pt 0cm 5.4pt" |  
-
&lt;o:p&gt;&nbsp;&lt;/o:p&gt;
+
&lt;o:p&gt;&nbsp;&lt;/o:p&gt;  
|- style="mso-yfti-irow:8"
|- style="mso-yfti-irow:8"
| width="350" valign="top" style="width:262.5pt;border:solid windowtext 1.0pt; border-top:none;mso-border-top-alt:solid windowtext .5pt;mso-border-alt:solid windowtext .5pt; padding:0cm 5.4pt 0cm 5.4pt" |  
| width="350" valign="top" style="width:262.5pt;border:solid windowtext 1.0pt; border-top:none;mso-border-top-alt:solid windowtext .5pt;mso-border-alt:solid windowtext .5pt; padding:0cm 5.4pt 0cm 5.4pt" |  
-
Geschiedenis per pagina van deze richtlijn (= huidige pagina)
+
Geschiedenis per pagina van deze richtlijn (= huidige pagina)  
| width="269" valign="top" style="width:201.9pt;border-top:none;border-left: none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt; mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid windowtext .5pt; mso-border-alt:solid windowtext .5pt;padding:0cm 5.4pt 0cm 5.4pt" |  
| width="269" valign="top" style="width:201.9pt;border-top:none;border-left: none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt; mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid windowtext .5pt; mso-border-alt:solid windowtext .5pt;padding:0cm 5.4pt 0cm 5.4pt" |  
-
&lt;o:p&gt;&nbsp;&lt;/o:p&gt;
+
&lt;o:p&gt;&nbsp;&lt;/o:p&gt;  
|- style="mso-yfti-irow:9"
|- style="mso-yfti-irow:9"
| width="350" valign="top" style="width:262.5pt;border:solid windowtext 1.0pt; border-top:none;mso-border-top-alt:solid windowtext .5pt;mso-border-alt:solid windowtext .5pt; padding:0cm 5.4pt 0cm 5.4pt" |  
| width="350" valign="top" style="width:262.5pt;border:solid windowtext 1.0pt; border-top:none;mso-border-top-alt:solid windowtext .5pt;mso-border-alt:solid windowtext .5pt; padding:0cm 5.4pt 0cm 5.4pt" |  
-
'''&lt;o:p&gt;&nbsp;&lt;/o:p&gt;'''
+
'''&lt;o:p&gt;&nbsp;&lt;/o:p&gt;'''  
| width="269" valign="top" style="width:201.9pt;border-top:none;border-left: none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt; mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid windowtext .5pt; mso-border-alt:solid windowtext .5pt;padding:0cm 5.4pt 0cm 5.4pt" |  
| width="269" valign="top" style="width:201.9pt;border-top:none;border-left: none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt; mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid windowtext .5pt; mso-border-alt:solid windowtext .5pt;padding:0cm 5.4pt 0cm 5.4pt" |  
-
<span style="mso-bidi-font-weight:bold">&lt;o:p&gt;&nbsp;&lt;/o:p&gt;</span>
+
<span style="mso-bidi-font-weight:bold">&lt;o:p&gt;&nbsp;&lt;/o:p&gt;</span>  
|- style="mso-yfti-irow:10"
|- style="mso-yfti-irow:10"
| width="350" valign="top" style="width:262.5pt;border:solid windowtext 1.0pt; border-top:none;mso-border-top-alt:solid windowtext .5pt;mso-border-alt:solid windowtext .5pt; padding:0cm 5.4pt 0cm 5.4pt" |  
| width="350" valign="top" style="width:262.5pt;border:solid windowtext 1.0pt; border-top:none;mso-border-top-alt:solid windowtext .5pt;mso-border-alt:solid windowtext .5pt; padding:0cm 5.4pt 0cm 5.4pt" |  
-
'''&lt;a'''
+
'''&lt;a'''  
-
'''href="http://www.nvhb.nl/richtlijnhiv/extensions/FCKeditor/fckeditor/editor/Hoofdstuk%202.%20Therapie%20bij%20volwassenen"&gt;Hoofdstuk'''
+
'''href="http://www.nvhb.nl/richtlijnhiv/extensions/FCKeditor/fckeditor/editor/Hoofdstuk%202.%20Therapie%20bij%20volwassenen"&gt;Hoofdstuk''' '''2. Therapie bij volwassenen&lt;/a&gt;&lt;o:p&gt;&lt;/o:p&gt;'''  
-
'''2. Therapie bij volwassenen&lt;/a&gt;&lt;o:p&gt;&lt;/o:p&gt;'''
+
 +
<br>
| width="269" valign="top" style="width:201.9pt;border-top:none;border-left: none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt; mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid windowtext .5pt; mso-border-alt:solid windowtext .5pt;padding:0cm 5.4pt 0cm 5.4pt" |  
| width="269" valign="top" style="width:201.9pt;border-top:none;border-left: none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt; mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid windowtext .5pt; mso-border-alt:solid windowtext .5pt;padding:0cm 5.4pt 0cm 5.4pt" |  
-
<span style="mso-bidi-font-weight:bold">&lt;o:p&gt;&nbsp;&lt;/o:p&gt;</span>
+
<span style="mso-bidi-font-weight:bold">&lt;o:p&gt;&nbsp;&lt;/o:p&gt;</span>  
|- style="mso-yfti-irow:11"
|- style="mso-yfti-irow:11"
Regel 107: Regel 109:
&lt;a  
&lt;a  
-
href="http://www.nvhb.nl/richtlijnhiv/extensions/FCKeditor/fckeditor/editor/2.1.%20Wanneer%20beginnen?"&gt;2.1.  
+
href="http://www.nvhb.nl/richtlijnhiv/extensions/FCKeditor/fckeditor/editor/2.1.%20Wanneer%20beginnen?"&gt;2.1. Wanneer beginnen?&lt;/a&gt;  
-
Wanneer beginnen?&lt;/a&gt;
+
 +
<br>
| width="269" valign="top" style="width:201.9pt;border-top:none;border-left: none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt; mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid windowtext .5pt; mso-border-alt:solid windowtext .5pt;padding:0cm 5.4pt 0cm 5.4pt" |  
| width="269" valign="top" style="width:201.9pt;border-top:none;border-left: none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt; mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid windowtext .5pt; mso-border-alt:solid windowtext .5pt;padding:0cm 5.4pt 0cm 5.4pt" |  
-
&lt;o:p&gt;&nbsp;&lt;/o:p&gt;
+
&lt;o:p&gt;&nbsp;&lt;/o:p&gt;  
|- style="mso-yfti-irow:12"
|- style="mso-yfti-irow:12"
Regel 118: Regel 120:
&lt;a  
&lt;a  
-
href="http://www.nvhb.nl/richtlijnhiv/extensions/FCKeditor/fckeditor/editor/Onderbouwing%20wanneer%20starten"&gt;Onderbouwing  
+
href="http://www.nvhb.nl/richtlijnhiv/extensions/FCKeditor/fckeditor/editor/Onderbouwing%20wanneer%20starten"&gt;Onderbouwing wanneer starten&lt;/a&gt;  
-
wanneer starten&lt;/a&gt;
+
 +
<br>
| width="269" valign="top" style="width:201.9pt;border-top:none;border-left: none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt; mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid windowtext .5pt; mso-border-alt:solid windowtext .5pt;padding:0cm 5.4pt 0cm 5.4pt" |  
| width="269" valign="top" style="width:201.9pt;border-top:none;border-left: none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt; mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid windowtext .5pt; mso-border-alt:solid windowtext .5pt;padding:0cm 5.4pt 0cm 5.4pt" |  
-
<span class="SpellE"><span class="GramE">Aidsinfo</span></span> NIH
+
<span class="SpellE"><span class="GramE">Aidsinfo</span></span> NIH  
|- style="mso-yfti-irow:13"
|- style="mso-yfti-irow:13"
Regel 129: Regel 131:
&lt;a  
&lt;a  
-
href="http://www.nvhb.nl/richtlijnhiv/extensions/FCKeditor/fckeditor/editor/Literatuur%202.1"&gt;Literatuur  
+
href="http://www.nvhb.nl/richtlijnhiv/extensions/FCKeditor/fckeditor/editor/Literatuur%202.1"&gt;Literatuur 2.1&lt;/a&gt;  
-
2.1&lt;/a&gt;
+
 +
<br>
| width="269" valign="top" style="width:201.9pt;border-top:none;border-left: none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt; mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid windowtext .5pt; mso-border-alt:solid windowtext .5pt;padding:0cm 5.4pt 0cm 5.4pt" |  
| width="269" valign="top" style="width:201.9pt;border-top:none;border-left: none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt; mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid windowtext .5pt; mso-border-alt:solid windowtext .5pt;padding:0cm 5.4pt 0cm 5.4pt" |  
-
&lt;o:p&gt;&nbsp;&lt;/o:p&gt;
+
&lt;o:p&gt;&nbsp;&lt;/o:p&gt;  
|- style="mso-yfti-irow:14"
|- style="mso-yfti-irow:14"
Regel 140: Regel 142:
&lt;a  
&lt;a  
-
href="http://www.nvhb.nl/richtlijnhiv/extensions/FCKeditor/fckeditor/editor/2.2.%20Keuze%20van%20antiretrovirale%20therapie%20bij%20na%C3%AFeve%20volwassen%20pati%C3%ABnten"&gt;2.2.  
+
href="http://www.nvhb.nl/richtlijnhiv/extensions/FCKeditor/fckeditor/editor/2.2.%20Keuze%20van%20antiretrovirale%20therapie%20bij%20na%C3%AFeve%20volwassen%20pati%C3%ABnten"&gt;2.2. Keuze van antiretrovirale therapie bij naïeve volwassen patiënten&lt;/a&gt;  
-
Keuze van antiretrovirale therapie bij naïeve volwassen patiënten&lt;/a&gt;
+
 +
<br>
| width="269" valign="top" style="width:201.9pt;border-top:none;border-left: none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt; mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid windowtext .5pt; mso-border-alt:solid windowtext .5pt;padding:0cm 5.4pt 0cm 5.4pt" |  
| width="269" valign="top" style="width:201.9pt;border-top:none;border-left: none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt; mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid windowtext .5pt; mso-border-alt:solid windowtext .5pt;padding:0cm 5.4pt 0cm 5.4pt" |  
-
<span class="SpellE"><span class="GramE">Aidsinfo</span></span> NIH
+
<span class="SpellE"><span class="GramE">Aidsinfo</span></span> NIH  
|- style="mso-yfti-irow:15"
|- style="mso-yfti-irow:15"
Regel 151: Regel 153:
&lt;a  
&lt;a  
-
href="http://www.nvhb.nl/richtlijnhiv/extensions/FCKeditor/fckeditor/editor/Literatuur%202.2"&gt;Literatuur  
+
href="http://www.nvhb.nl/richtlijnhiv/extensions/FCKeditor/fckeditor/editor/Literatuur%202.2"&gt;Literatuur 2.2&lt;/a&gt;  
-
2.2&lt;/a&gt;
+
 +
<br>
| width="269" valign="top" style="width:201.9pt;border-top:none;border-left: none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt; mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid windowtext .5pt; mso-border-alt:solid windowtext .5pt;padding:0cm 5.4pt 0cm 5.4pt" |  
| width="269" valign="top" style="width:201.9pt;border-top:none;border-left: none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt; mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid windowtext .5pt; mso-border-alt:solid windowtext .5pt;padding:0cm 5.4pt 0cm 5.4pt" |  
-
&lt;o:p&gt;&nbsp;&lt;/o:p&gt;
+
&lt;o:p&gt;&nbsp;&lt;/o:p&gt;  
|- style="mso-yfti-irow:16"
|- style="mso-yfti-irow:16"
Regel 162: Regel 164:
&lt;a  
&lt;a  
-
href="http://www.nvhb.nl/richtlijnhiv/extensions/FCKeditor/fckeditor/editor/2.3.%20Tijdelijk%20onderbreken%20van%20HAART"&gt;2.3.  
+
href="http://www.nvhb.nl/richtlijnhiv/extensions/FCKeditor/fckeditor/editor/2.3.%20Tijdelijk%20onderbreken%20van%20HAART"&gt;2.3. Tijdelijk onderbreken van HAART&lt;/a&gt;  
-
Tijdelijk onderbreken van HAART&lt;/a&gt;
+
 +
<br>
| width="269" valign="top" style="width:201.9pt;border-top:none;border-left: none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt; mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid windowtext .5pt; mso-border-alt:solid windowtext .5pt;padding:0cm 5.4pt 0cm 5.4pt" |  
| width="269" valign="top" style="width:201.9pt;border-top:none;border-left: none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt; mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid windowtext .5pt; mso-border-alt:solid windowtext .5pt;padding:0cm 5.4pt 0cm 5.4pt" |  
-
<span class="SpellE"><span class="GramE">Aidsinfo</span></span> NIH
+
<span class="SpellE"><span class="GramE">Aidsinfo</span></span> NIH  
|- style="mso-yfti-irow:17"
|- style="mso-yfti-irow:17"
Regel 173: Regel 175:
&lt;a  
&lt;a  
-
href="http://www.nvhb.nl/richtlijnhiv/extensions/FCKeditor/fckeditor/editor/T%C2%BD%20van%20antiretrovirale%20middelen"&gt;T½  
+
href="http://www.nvhb.nl/richtlijnhiv/extensions/FCKeditor/fckeditor/editor/T%C2%BD%20van%20antiretrovirale%20middelen"&gt;T½ van antiretrovirale middelen&lt;/a&gt;  
-
van antiretrovirale middelen&lt;/a&gt;
+
 +
<br>
| width="269" valign="top" style="width:201.9pt;border-top:none;border-left: none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt; mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid windowtext .5pt; mso-border-alt:solid windowtext .5pt;padding:0cm 5.4pt 0cm 5.4pt" |  
| width="269" valign="top" style="width:201.9pt;border-top:none;border-left: none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt; mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid windowtext .5pt; mso-border-alt:solid windowtext .5pt;padding:0cm 5.4pt 0cm 5.4pt" |  
-
&lt;o:p&gt;&nbsp;&lt;/o:p&gt;
+
&lt;o:p&gt;&nbsp;&lt;/o:p&gt;  
|- style="mso-yfti-irow:18"
|- style="mso-yfti-irow:18"
Regel 184: Regel 186:
&lt;a  
&lt;a  
-
href="http://www.nvhb.nl/richtlijnhiv/extensions/FCKeditor/fckeditor/editor/2.4.%20Richtlijn%20anti-retrovirale%20therapie%20bij%20voorbehandelde%20pati%C3%ABnten"&gt;2.4.  
+
href="http://www.nvhb.nl/richtlijnhiv/extensions/FCKeditor/fckeditor/editor/2.4.%20Richtlijn%20anti-retrovirale%20therapie%20bij%20voorbehandelde%20pati%C3%ABnten"&gt;2.4. Richtlijn <span class="SpellE">anti-retrovirale</span> therapie bij <span class="SpellE">voorbehandelde</span> patiënten&lt;/a&gt;  
-
Richtlijn <span class="SpellE">anti-retrovirale</span> therapie bij <span class="SpellE">voorbehandelde</span> patiënten&lt;/a&gt;
+
 +
<br>
| width="269" valign="top" style="width:201.9pt;border-top:none;border-left: none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt; mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid windowtext .5pt; mso-border-alt:solid windowtext .5pt;padding:0cm 5.4pt 0cm 5.4pt" |  
| width="269" valign="top" style="width:201.9pt;border-top:none;border-left: none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt; mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid windowtext .5pt; mso-border-alt:solid windowtext .5pt;padding:0cm 5.4pt 0cm 5.4pt" |  
-
<span class="SpellE"><span class="GramE">Aidsinfo</span></span> NIH
+
<span class="SpellE"><span class="GramE">Aidsinfo</span></span> NIH  
|- style="mso-yfti-irow:19"
|- style="mso-yfti-irow:19"
| width="350" valign="top" style="width:262.5pt;border:solid windowtext 1.0pt; border-top:none;mso-border-top-alt:solid windowtext .5pt;mso-border-alt:solid windowtext .5pt; padding:0cm 5.4pt 0cm 5.4pt" |  
| width="350" valign="top" style="width:262.5pt;border:solid windowtext 1.0pt; border-top:none;mso-border-top-alt:solid windowtext .5pt;mso-border-alt:solid windowtext .5pt; padding:0cm 5.4pt 0cm 5.4pt" |  
-
&lt;o:p&gt;&nbsp;&lt;/o:p&gt;
+
&lt;o:p&gt;&nbsp;&lt;/o:p&gt;  
| width="269" valign="top" style="width:201.9pt;border-top:none;border-left: none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt; mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid windowtext .5pt; mso-border-alt:solid windowtext .5pt;padding:0cm 5.4pt 0cm 5.4pt" |  
| width="269" valign="top" style="width:201.9pt;border-top:none;border-left: none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt; mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid windowtext .5pt; mso-border-alt:solid windowtext .5pt;padding:0cm 5.4pt 0cm 5.4pt" |  
-
&lt;o:p&gt;&nbsp;&lt;/o:p&gt;
+
&lt;o:p&gt;&nbsp;&lt;/o:p&gt;  
|- style="mso-yfti-irow:20"
|- style="mso-yfti-irow:20"
| width="350" valign="top" style="width:262.5pt;border:solid windowtext 1.0pt; border-top:none;mso-border-top-alt:solid windowtext .5pt;mso-border-alt:solid windowtext .5pt; padding:0cm 5.4pt 0cm 5.4pt" |  
| width="350" valign="top" style="width:262.5pt;border:solid windowtext 1.0pt; border-top:none;mso-border-top-alt:solid windowtext .5pt;mso-border-alt:solid windowtext .5pt; padding:0cm 5.4pt 0cm 5.4pt" |  
-
'''&lt;a'''
+
'''&lt;a'''  
-
'''href="http://www.nvhb.nl/richtlijnhiv/extensions/FCKeditor/fckeditor/editor/Hoofdstuk%203.%20Behandeling%20van%20HIV-1%20infectie%20bij%20kinderen"&gt;Hoofdstuk'''
+
'''href="http://www.nvhb.nl/richtlijnhiv/extensions/FCKeditor/fckeditor/editor/Hoofdstuk%203.%20Behandeling%20van%20HIV-1%20infectie%20bij%20kinderen"&gt;Hoofdstuk''' '''3. Behandeling van HIV-1 infectie bij kinderen&lt;/a&gt;&lt;o:p&gt;&lt;/o:p&gt;'''  
-
'''3. Behandeling van HIV-1 infectie bij kinderen&lt;/a&gt;&lt;o:p&gt;&lt;/o:p&gt;'''
+
 +
<br>
| width="269" valign="top" style="width:201.9pt;border-top:none;border-left: none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt; mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid windowtext .5pt; mso-border-alt:solid windowtext .5pt;padding:0cm 5.4pt 0cm 5.4pt" |  
| width="269" valign="top" style="width:201.9pt;border-top:none;border-left: none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt; mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid windowtext .5pt; mso-border-alt:solid windowtext .5pt;padding:0cm 5.4pt 0cm 5.4pt" |  
-
<span class="SpellE"><span style="mso-bidi-font-weight:bold">Penta</span></span><span style="mso-bidi-font-weight:bold">&lt;o:p&gt;&lt;/o:p&gt;</span>
+
<span class="SpellE"><span style="mso-bidi-font-weight:bold">Penta</span></span><span style="mso-bidi-font-weight:bold">&lt;o:p&gt;&lt;/o:p&gt;</span>  
<span class="SpellE"><span class="GramE"><span style="mso-bidi-font-weight: bold">Aidsinfo</span></span></span><span style="mso-bidi-font-weight:bold">
<span class="SpellE"><span class="GramE"><span style="mso-bidi-font-weight: bold">Aidsinfo</span></span></span><span style="mso-bidi-font-weight:bold">
-
NIH&lt;o:p&gt;&lt;/o:p&gt;</span>
+
NIH&lt;o:p&gt;&lt;/o:p&gt;</span>  
|- style="mso-yfti-irow:21"
|- style="mso-yfti-irow:21"
| width="350" valign="top" style="width:262.5pt;border:solid windowtext 1.0pt; border-top:none;mso-border-top-alt:solid windowtext .5pt;mso-border-alt:solid windowtext .5pt; padding:0cm 5.4pt 0cm 5.4pt" |  
| width="350" valign="top" style="width:262.5pt;border:solid windowtext 1.0pt; border-top:none;mso-border-top-alt:solid windowtext .5pt;mso-border-alt:solid windowtext .5pt; padding:0cm 5.4pt 0cm 5.4pt" |  
-
'''&lt;o:p&gt;&nbsp;&lt;/o:p&gt;'''
+
'''&lt;o:p&gt;&nbsp;&lt;/o:p&gt;'''  
| width="269" valign="top" style="width:201.9pt;border-top:none;border-left: none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt; mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid windowtext .5pt; mso-border-alt:solid windowtext .5pt;padding:0cm 5.4pt 0cm 5.4pt" |  
| width="269" valign="top" style="width:201.9pt;border-top:none;border-left: none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt; mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid windowtext .5pt; mso-border-alt:solid windowtext .5pt;padding:0cm 5.4pt 0cm 5.4pt" |  
-
<span style="mso-bidi-font-weight:bold">&lt;o:p&gt;&nbsp;&lt;/o:p&gt;</span>
+
<span style="mso-bidi-font-weight:bold">&lt;o:p&gt;&nbsp;&lt;/o:p&gt;</span>  
|- style="mso-yfti-irow:22"
|- style="mso-yfti-irow:22"
| width="350" valign="top" style="width:262.5pt;border:solid windowtext 1.0pt; border-top:none;mso-border-top-alt:solid windowtext .5pt;mso-border-alt:solid windowtext .5pt; padding:0cm 5.4pt 0cm 5.4pt" |  
| width="350" valign="top" style="width:262.5pt;border:solid windowtext 1.0pt; border-top:none;mso-border-top-alt:solid windowtext .5pt;mso-border-alt:solid windowtext .5pt; padding:0cm 5.4pt 0cm 5.4pt" |  
-
'''&lt;a'''
+
'''&lt;a'''  
-
'''href="http://www.nvhb.nl/richtlijnhiv/extensions/FCKeditor/fckeditor/editor/Hoofdstuk%204.%20Monitoring"&gt;Hoofdstuk'''
+
'''href="http://www.nvhb.nl/richtlijnhiv/extensions/FCKeditor/fckeditor/editor/Hoofdstuk%204.%20Monitoring"&gt;Hoofdstuk''' '''4. Monitoring&lt;/a&gt;&lt;o:p&gt;&lt;/o:p&gt;'''  
-
'''4. Monitoring&lt;/a&gt;&lt;o:p&gt;&lt;/o:p&gt;'''
+
 +
<br>
| width="269" valign="top" style="width:201.9pt;border-top:none;border-left: none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt; mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid windowtext .5pt; mso-border-alt:solid windowtext .5pt;padding:0cm 5.4pt 0cm 5.4pt" |  
| width="269" valign="top" style="width:201.9pt;border-top:none;border-left: none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt; mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid windowtext .5pt; mso-border-alt:solid windowtext .5pt;padding:0cm 5.4pt 0cm 5.4pt" |  
-
<span style="mso-bidi-font-weight:bold">&lt;o:p&gt;&nbsp;&lt;/o:p&gt;</span>
+
<span style="mso-bidi-font-weight:bold">&lt;o:p&gt;&nbsp;&lt;/o:p&gt;</span>  
|- style="mso-yfti-irow:23"
|- style="mso-yfti-irow:23"
Regel 234: Regel 236:
&lt;a  
&lt;a  
-
href="http://www.nvhb.nl/richtlijnhiv/extensions/FCKeditor/fckeditor/editor/4.1.%20Controles%20HIV-pati%C3%ABnten%20%28polikliniek%29"&gt;4.1.  
+
href="http://www.nvhb.nl/richtlijnhiv/extensions/FCKeditor/fckeditor/editor/4.1.%20Controles%20HIV-pati%C3%ABnten%20%28polikliniek%29"&gt;4.1. Controles HIV-patiënten (polikliniek)&lt;/a&gt;  
-
Controles HIV-patiënten (polikliniek)&lt;/a&gt;
+
 +
<br>
| width="269" valign="top" style="width:201.9pt;border-top:none;border-left: none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt; mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid windowtext .5pt; mso-border-alt:solid windowtext .5pt;padding:0cm 5.4pt 0cm 5.4pt" |  
| width="269" valign="top" style="width:201.9pt;border-top:none;border-left: none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt; mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid windowtext .5pt; mso-border-alt:solid windowtext .5pt;padding:0cm 5.4pt 0cm 5.4pt" |  
-
&lt;o:p&gt;&nbsp;&lt;/o:p&gt;
+
&lt;o:p&gt;&nbsp;&lt;/o:p&gt;  
|- style="mso-yfti-irow:24"
|- style="mso-yfti-irow:24"
Regel 245: Regel 247:
&lt;a  
&lt;a  
-
href="http://www.nvhb.nl/richtlijnhiv/extensions/FCKeditor/fckeditor/editor/Bij%20eerste%20consult%20bij%20HIV-seropositieve%20pati%C3%ABnt%20%28polikliniek%29"&gt;Bij eerste consult bij <span class="SpellE">HIV-seropositieve</span> patiënt (polikliniek)&lt;/a&gt;&lt;a href="http://www.nvhb.nl/richtlijnhiv/extensions/FCKeditor/fckeditor/editor/Bij%20instellen%20op%20antiretrovirale%20therapie%20%28polikliniek%29" _fcknotitle=true _fcksavedurl="Bij instellen op antiretrovirale therapie (polikliniek)"&gt;Bij  
+
href="http://www.nvhb.nl/richtlijnhiv/extensions/FCKeditor/fckeditor/editor/Bij%20eerste%20consult%20bij%20HIV-seropositieve%20pati%C3%ABnt%20%28polikliniek%29"&gt;Bij eerste consult bij <span class="SpellE">HIV-seropositieve</span> patiënt (polikliniek)&lt;/a&gt;&lt;a href="http://www.nvhb.nl/richtlijnhiv/extensions/FCKeditor/fckeditor/editor/Bij%20instellen%20op%20antiretrovirale%20therapie%20%28polikliniek%29" _fcknotitle=true _fcksavedurl="Bij instellen op antiretrovirale therapie (polikliniek)"&gt;Bij instellen op antiretrovirale therapie (polikliniek)&lt;/a&gt;  
-
instellen op antiretrovirale therapie (polikliniek)&lt;/a&gt;
+
 +
<br>
| width="269" valign="top" style="width:201.9pt;border-top:none;border-left: none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt; mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid windowtext .5pt; mso-border-alt:solid windowtext .5pt;padding:0cm 5.4pt 0cm 5.4pt" |  
| width="269" valign="top" style="width:201.9pt;border-top:none;border-left: none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt; mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid windowtext .5pt; mso-border-alt:solid windowtext .5pt;padding:0cm 5.4pt 0cm 5.4pt" |  
-
&lt;o:p&gt;&nbsp;&lt;/o:p&gt;
+
&lt;o:p&gt;&nbsp;&lt;/o:p&gt;  
|- style="mso-yfti-irow:25"
|- style="mso-yfti-irow:25"
Regel 256: Regel 258:
&lt;a  
&lt;a  
-
href="http://www.nvhb.nl/richtlijnhiv/extensions/FCKeditor/fckeditor/editor/Eerste%20controle%20na%20instellen%20op%20anti-retrovirale%20therapie%204-6%20weken%20na%20start%20%28polikliniek%29"&gt;Eerste controle na instellen op <span class="SpellE">anti-retrovirale</span> therapie  
+
href="http://www.nvhb.nl/richtlijnhiv/extensions/FCKeditor/fckeditor/editor/Eerste%20controle%20na%20instellen%20op%20anti-retrovirale%20therapie%204-6%20weken%20na%20start%20%28polikliniek%29"&gt;Eerste controle na instellen op <span class="SpellE">anti-retrovirale</span> therapie 4-6 weken na start (polikliniek)&lt;/a&gt;  
-
4-6 weken na start (polikliniek)&lt;/a&gt;
+
 +
<br>
| width="269" valign="top" style="width:201.9pt;border-top:none;border-left: none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt; mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid windowtext .5pt; mso-border-alt:solid windowtext .5pt;padding:0cm 5.4pt 0cm 5.4pt" |  
| width="269" valign="top" style="width:201.9pt;border-top:none;border-left: none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt; mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid windowtext .5pt; mso-border-alt:solid windowtext .5pt;padding:0cm 5.4pt 0cm 5.4pt" |  
-
&lt;o:p&gt;&nbsp;&lt;/o:p&gt;
+
&lt;o:p&gt;&nbsp;&lt;/o:p&gt;  
|- style="mso-yfti-irow:26"
|- style="mso-yfti-irow:26"
Regel 267: Regel 269:
&lt;a  
&lt;a  
-
href="http://www.nvhb.nl/richtlijnhiv/extensions/FCKeditor/fckeditor/editor/Controle%20van%20pati%C3%ABnten%20op%20antiretrovirale%20therapie%20%28polikliniek%29"&gt;Controle  
+
href="http://www.nvhb.nl/richtlijnhiv/extensions/FCKeditor/fckeditor/editor/Controle%20van%20pati%C3%ABnten%20op%20antiretrovirale%20therapie%20%28polikliniek%29"&gt;Controle van patiënten op antiretrovirale therapie (polikliniek)&lt;/a&gt;  
-
van patiënten op antiretrovirale therapie (polikliniek)&lt;/a&gt;
+
 +
<br>
| width="269" valign="top" style="width:201.9pt;border-top:none;border-left: none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt; mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid windowtext .5pt; mso-border-alt:solid windowtext .5pt;padding:0cm 5.4pt 0cm 5.4pt" |  
| width="269" valign="top" style="width:201.9pt;border-top:none;border-left: none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt; mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid windowtext .5pt; mso-border-alt:solid windowtext .5pt;padding:0cm 5.4pt 0cm 5.4pt" |  
-
&lt;o:p&gt;&nbsp;&lt;/o:p&gt;
+
&lt;o:p&gt;&nbsp;&lt;/o:p&gt;  
|- style="mso-yfti-irow:27"
|- style="mso-yfti-irow:27"
Regel 278: Regel 280:
&lt;a  
&lt;a  
-
href="http://www.nvhb.nl/richtlijnhiv/extensions/FCKeditor/fckeditor/editor/Controle%20van%20pati%C3%ABnten%20zonder%20antiretrovirale%20therapie%20%28polikliniek%29"&gt;Controle  
+
href="http://www.nvhb.nl/richtlijnhiv/extensions/FCKeditor/fckeditor/editor/Controle%20van%20pati%C3%ABnten%20zonder%20antiretrovirale%20therapie%20%28polikliniek%29"&gt;Controle van patiënten zonder antiretrovirale therapie (polikliniek)&lt;/a&gt;  
-
van patiënten zonder antiretrovirale therapie (polikliniek)&lt;/a&gt;
+
 +
<br>
| width="269" valign="top" style="width:201.9pt;border-top:none;border-left: none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt; mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid windowtext .5pt; mso-border-alt:solid windowtext .5pt;padding:0cm 5.4pt 0cm 5.4pt" |  
| width="269" valign="top" style="width:201.9pt;border-top:none;border-left: none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt; mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid windowtext .5pt; mso-border-alt:solid windowtext .5pt;padding:0cm 5.4pt 0cm 5.4pt" |  
-
&lt;o:p&gt;&nbsp;&lt;/o:p&gt;
+
&lt;o:p&gt;&nbsp;&lt;/o:p&gt;  
|- style="mso-yfti-irow:28"
|- style="mso-yfti-irow:28"
Regel 289: Regel 291:
&lt;a  
&lt;a  
-
href="http://www.nvhb.nl/richtlijnhiv/extensions/FCKeditor/fckeditor/editor/4.2.%20Spiegelbepaling"&gt;4.2.  
+
href="http://www.nvhb.nl/richtlijnhiv/extensions/FCKeditor/fckeditor/editor/4.2.%20Spiegelbepaling"&gt;4.2. Spiegelbepaling&lt;/a&gt;  
-
Spiegelbepaling&lt;/a&gt;
+
 +
<br>
| width="269" valign="top" style="width:201.9pt;border-top:none;border-left: none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt; mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid windowtext .5pt; mso-border-alt:solid windowtext .5pt;padding:0cm 5.4pt 0cm 5.4pt" |  
| width="269" valign="top" style="width:201.9pt;border-top:none;border-left: none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt; mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid windowtext .5pt; mso-border-alt:solid windowtext .5pt;padding:0cm 5.4pt 0cm 5.4pt" |  
-
&lt;o:p&gt;&nbsp;&lt;/o:p&gt;
+
&lt;o:p&gt;&nbsp;&lt;/o:p&gt;  
|- style="mso-yfti-irow:29"
|- style="mso-yfti-irow:29"
Regel 300: Regel 302:
&lt;a  
&lt;a  
-
href="http://www.nvhb.nl/richtlijnhiv/extensions/FCKeditor/fckeditor/editor/4.3.%20Resistentiebepalingen"&gt;4.3.  
+
href="http://www.nvhb.nl/richtlijnhiv/extensions/FCKeditor/fckeditor/editor/4.3.%20Resistentiebepalingen"&gt;4.3. Resistentiebepalingen&lt;/a&gt;  
-
Resistentiebepalingen&lt;/a&gt;
+
 +
<br>
| width="269" valign="top" style="width:201.9pt;border-top:none;border-left: none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt; mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid windowtext .5pt; mso-border-alt:solid windowtext .5pt;padding:0cm 5.4pt 0cm 5.4pt" |  
| width="269" valign="top" style="width:201.9pt;border-top:none;border-left: none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt; mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid windowtext .5pt; mso-border-alt:solid windowtext .5pt;padding:0cm 5.4pt 0cm 5.4pt" |  
-
&lt;o:p&gt;&nbsp;&lt;/o:p&gt;
+
&lt;o:p&gt;&nbsp;&lt;/o:p&gt;  
|- style="mso-yfti-irow:30"
|- style="mso-yfti-irow:30"
| width="350" valign="top" style="width:262.5pt;border:solid windowtext 1.0pt; border-top:none;mso-border-top-alt:solid windowtext .5pt;mso-border-alt:solid windowtext .5pt; padding:0cm 5.4pt 0cm 5.4pt" |  
| width="350" valign="top" style="width:262.5pt;border:solid windowtext 1.0pt; border-top:none;mso-border-top-alt:solid windowtext .5pt;mso-border-alt:solid windowtext .5pt; padding:0cm 5.4pt 0cm 5.4pt" |  
-
'''&lt;o:p&gt;&nbsp;&lt;/o:p&gt;'''
+
'''&lt;o:p&gt;&nbsp;&lt;/o:p&gt;'''  
| width="269" valign="top" style="width:201.9pt;border-top:none;border-left: none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt; mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid windowtext .5pt; mso-border-alt:solid windowtext .5pt;padding:0cm 5.4pt 0cm 5.4pt" |  
| width="269" valign="top" style="width:201.9pt;border-top:none;border-left: none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt; mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid windowtext .5pt; mso-border-alt:solid windowtext .5pt;padding:0cm 5.4pt 0cm 5.4pt" |  
-
<span style="mso-bidi-font-weight:bold">&lt;o:p&gt;&nbsp;&lt;/o:p&gt;</span>
+
<span style="mso-bidi-font-weight:bold">&lt;o:p&gt;&nbsp;&lt;/o:p&gt;</span>  
|- style="mso-yfti-irow:31"
|- style="mso-yfti-irow:31"
| width="350" valign="top" style="width:262.5pt;border:solid windowtext 1.0pt; border-top:none;mso-border-top-alt:solid windowtext .5pt;mso-border-alt:solid windowtext .5pt; padding:0cm 5.4pt 0cm 5.4pt" |  
| width="350" valign="top" style="width:262.5pt;border:solid windowtext 1.0pt; border-top:none;mso-border-top-alt:solid windowtext .5pt;mso-border-alt:solid windowtext .5pt; padding:0cm 5.4pt 0cm 5.4pt" |  
-
'''&lt;a'''
+
'''&lt;a'''  
-
'''href="http://www.nvhb.nl/richtlijnhiv/extensions/FCKeditor/fckeditor/editor/Hoofdstuk%205.%20Diagnostiek%20en%20behandeling%20primaire%20HIV-infectie"&gt;Hoofdstuk'''
+
'''href="http://www.nvhb.nl/richtlijnhiv/extensions/FCKeditor/fckeditor/editor/Hoofdstuk%205.%20Diagnostiek%20en%20behandeling%20primaire%20HIV-infectie"&gt;Hoofdstuk''' '''5. Diagnostiek en behandeling primaire <span class="SpellE">HIV-infectie</span>&lt;/a&gt;&lt;o:p&gt;&lt;/o:p&gt;'''  
-
'''5. Diagnostiek en behandeling primaire <span class="SpellE">HIV-infectie</span>&lt;/a&gt;&lt;o:p&gt;&lt;/o:p&gt;'''
+
 +
<br>
| width="269" valign="top" style="width:201.9pt;border-top:none;border-left: none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt; mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid windowtext .5pt; mso-border-alt:solid windowtext .5pt;padding:0cm 5.4pt 0cm 5.4pt" |  
| width="269" valign="top" style="width:201.9pt;border-top:none;border-left: none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt; mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid windowtext .5pt; mso-border-alt:solid windowtext .5pt;padding:0cm 5.4pt 0cm 5.4pt" |  
<span class="SpellE"><span class="GramE"><span style="mso-bidi-font-weight: bold">Aidsinfo</span></span></span><span style="mso-bidi-font-weight:bold">
<span class="SpellE"><span class="GramE"><span style="mso-bidi-font-weight: bold">Aidsinfo</span></span></span><span style="mso-bidi-font-weight:bold">
-
NIH&lt;o:p&gt;&lt;/o:p&gt;</span>
+
NIH&lt;o:p&gt;&lt;/o:p&gt;</span>  
|- style="mso-yfti-irow:32"
|- style="mso-yfti-irow:32"
| width="350" valign="top" style="width:262.5pt;border:solid windowtext 1.0pt; border-top:none;mso-border-top-alt:solid windowtext .5pt;mso-border-alt:solid windowtext .5pt; padding:0cm 5.4pt 0cm 5.4pt" |  
| width="350" valign="top" style="width:262.5pt;border:solid windowtext 1.0pt; border-top:none;mso-border-top-alt:solid windowtext .5pt;mso-border-alt:solid windowtext .5pt; padding:0cm 5.4pt 0cm 5.4pt" |  
-
'''&lt;o:p&gt;&nbsp;&lt;/o:p&gt;'''
+
'''&lt;o:p&gt;&nbsp;&lt;/o:p&gt;'''  
| width="269" valign="top" style="width:201.9pt;border-top:none;border-left: none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt; mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid windowtext .5pt; mso-border-alt:solid windowtext .5pt;padding:0cm 5.4pt 0cm 5.4pt" |  
| width="269" valign="top" style="width:201.9pt;border-top:none;border-left: none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt; mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid windowtext .5pt; mso-border-alt:solid windowtext .5pt;padding:0cm 5.4pt 0cm 5.4pt" |  
-
<span style="mso-bidi-font-weight:bold">&lt;o:p&gt;&nbsp;&lt;/o:p&gt;</span>
+
<span style="mso-bidi-font-weight:bold">&lt;o:p&gt;&nbsp;&lt;/o:p&gt;</span>  
|- style="mso-yfti-irow:33"
|- style="mso-yfti-irow:33"
| width="350" valign="top" style="width:262.5pt;border:solid windowtext 1.0pt; border-top:none;mso-border-top-alt:solid windowtext .5pt;mso-border-alt:solid windowtext .5pt; padding:0cm 5.4pt 0cm 5.4pt" |  
| width="350" valign="top" style="width:262.5pt;border:solid windowtext 1.0pt; border-top:none;mso-border-top-alt:solid windowtext .5pt;mso-border-alt:solid windowtext .5pt; padding:0cm 5.4pt 0cm 5.4pt" |  
-
'''&lt;a'''
+
'''&lt;a'''  
-
'''href="http://www.nvhb.nl/richtlijnhiv/extensions/FCKeditor/fckeditor/editor/Hoofdstuk%206.%20Therapietrouw%20bevorderende%20maatregelen"&gt;Hoofdstuk'''
+
'''href="http://www.nvhb.nl/richtlijnhiv/extensions/FCKeditor/fckeditor/editor/Hoofdstuk%206.%20Therapietrouw%20bevorderende%20maatregelen"&gt;Hoofdstuk''' '''6. Therapietrouw bevorderende maatregelen&lt;/a&gt;&lt;o:p&gt;&lt;/o:p&gt;'''  
-
'''6. Therapietrouw bevorderende maatregelen&lt;/a&gt;&lt;o:p&gt;&lt;/o:p&gt;'''
+
 +
<br>
| width="269" valign="top" style="width:201.9pt;border-top:none;border-left: none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt; mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid windowtext .5pt; mso-border-alt:solid windowtext .5pt;padding:0cm 5.4pt 0cm 5.4pt" |  
| width="269" valign="top" style="width:201.9pt;border-top:none;border-left: none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt; mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid windowtext .5pt; mso-border-alt:solid windowtext .5pt;padding:0cm 5.4pt 0cm 5.4pt" |  
-
<span style="mso-bidi-font-weight:bold">&lt;o:p&gt;&nbsp;&lt;/o:p&gt;</span>
+
<span style="mso-bidi-font-weight:bold">&lt;o:p&gt;&nbsp;&lt;/o:p&gt;</span>  
|- style="mso-yfti-irow:34"
|- style="mso-yfti-irow:34"
Regel 348: Regel 350:
&lt;a  
&lt;a  
-
href="http://www.nvhb.nl/richtlijnhiv/extensions/FCKeditor/fckeditor/editor/6.1.%20Therapietrouw%20be%C3%AFnvloedende%20factoren"&gt;6.1.  
+
href="http://www.nvhb.nl/richtlijnhiv/extensions/FCKeditor/fckeditor/editor/6.1.%20Therapietrouw%20be%C3%AFnvloedende%20factoren"&gt;6.1. Therapietrouw beïnvloedende factoren&lt;/a&gt;  
-
Therapietrouw beïnvloedende factoren&lt;/a&gt;
+
 +
<br>
| width="269" valign="top" style="width:201.9pt;border-top:none;border-left: none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt; mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid windowtext .5pt; mso-border-alt:solid windowtext .5pt;padding:0cm 5.4pt 0cm 5.4pt" |  
| width="269" valign="top" style="width:201.9pt;border-top:none;border-left: none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt; mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid windowtext .5pt; mso-border-alt:solid windowtext .5pt;padding:0cm 5.4pt 0cm 5.4pt" |  
-
&lt;o:p&gt;&nbsp;&lt;/o:p&gt;
+
&lt;o:p&gt;&nbsp;&lt;/o:p&gt;  
|- style="mso-yfti-irow:35"
|- style="mso-yfti-irow:35"
Regel 359: Regel 361:
&lt;a  
&lt;a  
-
href="http://www.nvhb.nl/richtlijnhiv/extensions/FCKeditor/fckeditor/editor/Literatuur%206.1"&gt;Literatuur  
+
href="http://www.nvhb.nl/richtlijnhiv/extensions/FCKeditor/fckeditor/editor/Literatuur%206.1"&gt;Literatuur 6.1&lt;/a&gt;  
-
6.1&lt;/a&gt;
+
 +
<br>
| width="269" valign="top" style="width:201.9pt;border-top:none;border-left: none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt; mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid windowtext .5pt; mso-border-alt:solid windowtext .5pt;padding:0cm 5.4pt 0cm 5.4pt" |  
| width="269" valign="top" style="width:201.9pt;border-top:none;border-left: none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt; mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid windowtext .5pt; mso-border-alt:solid windowtext .5pt;padding:0cm 5.4pt 0cm 5.4pt" |  
-
&lt;o:p&gt;&nbsp;&lt;/o:p&gt;
+
&lt;o:p&gt;&nbsp;&lt;/o:p&gt;  
|- style="mso-yfti-irow:36"
|- style="mso-yfti-irow:36"
Regel 370: Regel 372:
&lt;a  
&lt;a  
-
href="http://www.nvhb.nl/richtlijnhiv/extensions/FCKeditor/fckeditor/editor/6.2.%20Therapietrouw%20bevorderende%20interventies"&gt;6.2.  
+
href="http://www.nvhb.nl/richtlijnhiv/extensions/FCKeditor/fckeditor/editor/6.2.%20Therapietrouw%20bevorderende%20interventies"&gt;6.2. Therapietrouw bevorderende interventies&lt;/a&gt;  
-
Therapietrouw bevorderende interventies&lt;/a&gt;
+
 +
<br>
| width="269" valign="top" style="width:201.9pt;border-top:none;border-left: none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt; mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid windowtext .5pt; mso-border-alt:solid windowtext .5pt;padding:0cm 5.4pt 0cm 5.4pt" |  
| width="269" valign="top" style="width:201.9pt;border-top:none;border-left: none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt; mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid windowtext .5pt; mso-border-alt:solid windowtext .5pt;padding:0cm 5.4pt 0cm 5.4pt" |  
-
&lt;o:p&gt;&nbsp;&lt;/o:p&gt;
+
&lt;o:p&gt;&nbsp;&lt;/o:p&gt;  
|- style="mso-yfti-irow:37"
|- style="mso-yfti-irow:37"
Regel 381: Regel 383:
&lt;a  
&lt;a  
-
href="http://www.nvhb.nl/richtlijnhiv/extensions/FCKeditor/fckeditor/editor/Onderbouwing%20therapietrouw%20bevorderende%20interventies"&gt;Onderbouwing  
+
href="http://www.nvhb.nl/richtlijnhiv/extensions/FCKeditor/fckeditor/editor/Onderbouwing%20therapietrouw%20bevorderende%20interventies"&gt;Onderbouwing therapietrouw bevorderende interventies&lt;/a&gt;  
-
therapietrouw bevorderende interventies&lt;/a&gt;
+
 +
<br>
| width="269" valign="top" style="width:201.9pt;border-top:none;border-left: none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt; mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid windowtext .5pt; mso-border-alt:solid windowtext .5pt;padding:0cm 5.4pt 0cm 5.4pt" |  
| width="269" valign="top" style="width:201.9pt;border-top:none;border-left: none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt; mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid windowtext .5pt; mso-border-alt:solid windowtext .5pt;padding:0cm 5.4pt 0cm 5.4pt" |  
-
&lt;o:p&gt;&nbsp;&lt;/o:p&gt;
+
&lt;o:p&gt;&nbsp;&lt;/o:p&gt;  
|- style="mso-yfti-irow:38"
|- style="mso-yfti-irow:38"
Regel 392: Regel 394:
&lt;a  
&lt;a  
-
href="http://www.nvhb.nl/richtlijnhiv/extensions/FCKeditor/fckeditor/editor/Literatuur%206.2"&gt;Literatuur  
+
href="http://www.nvhb.nl/richtlijnhiv/extensions/FCKeditor/fckeditor/editor/Literatuur%206.2"&gt;Literatuur 6.2&lt;/a&gt;  
-
6.2&lt;/a&gt;
+
 +
<br>
| width="269" valign="top" style="width:201.9pt;border-top:none;border-left: none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt; mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid windowtext .5pt; mso-border-alt:solid windowtext .5pt;padding:0cm 5.4pt 0cm 5.4pt" |  
| width="269" valign="top" style="width:201.9pt;border-top:none;border-left: none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt; mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid windowtext .5pt; mso-border-alt:solid windowtext .5pt;padding:0cm 5.4pt 0cm 5.4pt" |  
-
&lt;o:p&gt;&nbsp;&lt;/o:p&gt;
+
&lt;o:p&gt;&nbsp;&lt;/o:p&gt;  
|- style="mso-yfti-irow:39"
|- style="mso-yfti-irow:39"
| width="350" valign="top" style="width:262.5pt;border:solid windowtext 1.0pt; border-top:none;mso-border-top-alt:solid windowtext .5pt;mso-border-alt:solid windowtext .5pt; padding:0cm 5.4pt 0cm 5.4pt" |  
| width="350" valign="top" style="width:262.5pt;border:solid windowtext 1.0pt; border-top:none;mso-border-top-alt:solid windowtext .5pt;mso-border-alt:solid windowtext .5pt; padding:0cm 5.4pt 0cm 5.4pt" |  
-
'''&lt;o:p&gt;&nbsp;&lt;/o:p&gt;'''
+
'''&lt;o:p&gt;&nbsp;&lt;/o:p&gt;'''  
| width="269" valign="top" style="width:201.9pt;border-top:none;border-left: none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt; mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid windowtext .5pt; mso-border-alt:solid windowtext .5pt;padding:0cm 5.4pt 0cm 5.4pt" |  
| width="269" valign="top" style="width:201.9pt;border-top:none;border-left: none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt; mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid windowtext .5pt; mso-border-alt:solid windowtext .5pt;padding:0cm 5.4pt 0cm 5.4pt" |  
-
<span style="mso-bidi-font-weight:bold">&lt;o:p&gt;&nbsp;&lt;/o:p&gt;</span>
+
<span style="mso-bidi-font-weight:bold">&lt;o:p&gt;&nbsp;&lt;/o:p&gt;</span>  
|- style="mso-yfti-irow:40"
|- style="mso-yfti-irow:40"
| width="350" valign="top" style="width:262.5pt;border:solid windowtext 1.0pt; border-top:none;mso-border-top-alt:solid windowtext .5pt;mso-border-alt:solid windowtext .5pt; padding:0cm 5.4pt 0cm 5.4pt" |  
| width="350" valign="top" style="width:262.5pt;border:solid windowtext 1.0pt; border-top:none;mso-border-top-alt:solid windowtext .5pt;mso-border-alt:solid windowtext .5pt; padding:0cm 5.4pt 0cm 5.4pt" |  
-
'''&lt;a'''
+
'''&lt;a'''  
-
'''href="http://www.nvhb.nl/richtlijnhiv/extensions/FCKeditor/fckeditor/editor/Hoofdstuk%207.%20Preventie%20van%20moeder-kind%20overdracht:%20zwangerschap,%20bevalling%20en%20neonatale%20periode"&gt;Hoofdstuk 7. Preventie van moeder-kind overdracht: zwangerschap, bevalling en neonatale'''
+
'''href="http://www.nvhb.nl/richtlijnhiv/extensions/FCKeditor/fckeditor/editor/Hoofdstuk%207.%20Preventie%20van%20moeder-kind%20overdracht:%20zwangerschap,%20bevalling%20en%20neonatale%20periode"&gt;Hoofdstuk 7. Preventie van moeder-kind overdracht: zwangerschap, bevalling en neonatale''' '''periode&lt;/a&gt;&lt;o:p&gt;&lt;/o:p&gt;'''  
-
'''periode&lt;/a&gt;&lt;o:p&gt;&lt;/o:p&gt;'''
+
 +
<br>
| width="269" valign="top" style="width:201.9pt;border-top:none;border-left: none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt; mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid windowtext .5pt; mso-border-alt:solid windowtext .5pt;padding:0cm 5.4pt 0cm 5.4pt" |  
| width="269" valign="top" style="width:201.9pt;border-top:none;border-left: none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt; mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid windowtext .5pt; mso-border-alt:solid windowtext .5pt;padding:0cm 5.4pt 0cm 5.4pt" |  
<span class="SpellE"><span class="GramE"><span style="mso-bidi-font-weight: bold">Aidsinfo</span></span></span><span style="mso-bidi-font-weight:bold">
<span class="SpellE"><span class="GramE"><span style="mso-bidi-font-weight: bold">Aidsinfo</span></span></span><span style="mso-bidi-font-weight:bold">
-
NIH Perinatal&lt;o:p&gt;&lt;/o:p&gt;</span>
+
NIH Perinatal&lt;o:p&gt;&lt;/o:p&gt;</span>  
-
<span style="mso-bidi-font-weight:bold">NVHB Richtlijn 2007&lt;o:p&gt;&lt;/o:p&gt;</span>
+
<span style="mso-bidi-font-weight:bold">NVHB Richtlijn 2007&lt;o:p&gt;&lt;/o:p&gt;</span>  
|- style="mso-yfti-irow:41"
|- style="mso-yfti-irow:41"
Regel 424: Regel 426:
&lt;a  
&lt;a  
-
href="http://www.nvhb.nl/richtlijnhiv/extensions/FCKeditor/fckeditor/editor/Literatuur%207"&gt;Literatuur  
+
href="http://www.nvhb.nl/richtlijnhiv/extensions/FCKeditor/fckeditor/editor/Literatuur%207"&gt;Literatuur 7&lt;/a&gt;  
-
7&lt;/a&gt;
+
 +
<br>
| width="269" valign="top" style="width:201.9pt;border-top:none;border-left: none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt; mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid windowtext .5pt; mso-border-alt:solid windowtext .5pt;padding:0cm 5.4pt 0cm 5.4pt" |  
| width="269" valign="top" style="width:201.9pt;border-top:none;border-left: none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt; mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid windowtext .5pt; mso-border-alt:solid windowtext .5pt;padding:0cm 5.4pt 0cm 5.4pt" |  
-
&lt;o:p&gt;&nbsp;&lt;/o:p&gt;
+
&lt;o:p&gt;&nbsp;&lt;/o:p&gt;  
|- style="mso-yfti-irow:42"
|- style="mso-yfti-irow:42"
| width="350" valign="top" style="width:262.5pt;border:solid windowtext 1.0pt; border-top:none;mso-border-top-alt:solid windowtext .5pt;mso-border-alt:solid windowtext .5pt; padding:0cm 5.4pt 0cm 5.4pt" |  
| width="350" valign="top" style="width:262.5pt;border:solid windowtext 1.0pt; border-top:none;mso-border-top-alt:solid windowtext .5pt;mso-border-alt:solid windowtext .5pt; padding:0cm 5.4pt 0cm 5.4pt" |  
-
&lt;o:p&gt;&nbsp;&lt;/o:p&gt;
+
&lt;o:p&gt;&nbsp;&lt;/o:p&gt;  
| width="269" valign="top" style="width:201.9pt;border-top:none;border-left: none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt; mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid windowtext .5pt; mso-border-alt:solid windowtext .5pt;padding:0cm 5.4pt 0cm 5.4pt" |  
| width="269" valign="top" style="width:201.9pt;border-top:none;border-left: none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt; mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid windowtext .5pt; mso-border-alt:solid windowtext .5pt;padding:0cm 5.4pt 0cm 5.4pt" |  
-
&lt;o:p&gt;&nbsp;&lt;/o:p&gt;
+
&lt;o:p&gt;&nbsp;&lt;/o:p&gt;  
|- style="mso-yfti-irow:43"
|- style="mso-yfti-irow:43"
| width="350" valign="top" style="width:262.5pt;border:solid windowtext 1.0pt; border-top:none;mso-border-top-alt:solid windowtext .5pt;mso-border-alt:solid windowtext .5pt; padding:0cm 5.4pt 0cm 5.4pt" |  
| width="350" valign="top" style="width:262.5pt;border:solid windowtext 1.0pt; border-top:none;mso-border-top-alt:solid windowtext .5pt;mso-border-alt:solid windowtext .5pt; padding:0cm 5.4pt 0cm 5.4pt" |  
-
'''&lt;a'''
+
'''&lt;a'''  
-
'''href="http://www.nvhb.nl/richtlijnhiv/extensions/FCKeditor/fckeditor/editor/Hoofdstuk%208.%20HIV-2%20bij%20volwassenen:%20Behandeling%20en%20monitoring"&gt;Hoofdstuk'''
+
'''href="http://www.nvhb.nl/richtlijnhiv/extensions/FCKeditor/fckeditor/editor/Hoofdstuk%208.%20HIV-2%20bij%20volwassenen:%20Behandeling%20en%20monitoring"&gt;Hoofdstuk''' '''8. HIV-2 bij volwassenen: Behandeling en monitoring&lt;/a&gt;&lt;o:p&gt;&lt;/o:p&gt;'''  
-
'''8. HIV-2 bij volwassenen: Behandeling en monitoring&lt;/a&gt;&lt;o:p&gt;&lt;/o:p&gt;'''
+
 +
<br>
| width="269" valign="top" style="width:201.9pt;border-top:none;border-left: none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt; mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid windowtext .5pt; mso-border-alt:solid windowtext .5pt;padding:0cm 5.4pt 0cm 5.4pt" |  
| width="269" valign="top" style="width:201.9pt;border-top:none;border-left: none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt; mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid windowtext .5pt; mso-border-alt:solid windowtext .5pt;padding:0cm 5.4pt 0cm 5.4pt" |  
<span class="SpellE"><span class="GramE"><span style="mso-bidi-font-weight: bold">Aidsinfo</span></span></span><span style="mso-bidi-font-weight:bold">
<span class="SpellE"><span class="GramE"><span style="mso-bidi-font-weight: bold">Aidsinfo</span></span></span><span style="mso-bidi-font-weight:bold">
-
NIH&lt;o:p&gt;&lt;/o:p&gt;</span>
+
NIH&lt;o:p&gt;&lt;/o:p&gt;</span>  
|- style="mso-yfti-irow:44"
|- style="mso-yfti-irow:44"
Regel 454: Regel 456:
&lt;a  
&lt;a  
-
href="http://www.nvhb.nl/richtlijnhiv/extensions/FCKeditor/fckeditor/editor/Literatuur%208"&gt;Literatuur  
+
href="http://www.nvhb.nl/richtlijnhiv/extensions/FCKeditor/fckeditor/editor/Literatuur%208"&gt;Literatuur 8&lt;/a&gt;  
-
8&lt;/a&gt;
+
 +
<br>
| width="269" valign="top" style="width:201.9pt;border-top:none;border-left: none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt; mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid windowtext .5pt; mso-border-alt:solid windowtext .5pt;padding:0cm 5.4pt 0cm 5.4pt" |  
| width="269" valign="top" style="width:201.9pt;border-top:none;border-left: none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt; mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid windowtext .5pt; mso-border-alt:solid windowtext .5pt;padding:0cm 5.4pt 0cm 5.4pt" |  
-
&lt;o:p&gt;&nbsp;&lt;/o:p&gt;
+
&lt;o:p&gt;&nbsp;&lt;/o:p&gt;  
|- style="mso-yfti-irow:45"
|- style="mso-yfti-irow:45"
| width="350" valign="top" style="width:262.5pt;border:solid windowtext 1.0pt; border-top:none;mso-border-top-alt:solid windowtext .5pt;mso-border-alt:solid windowtext .5pt; padding:0cm 5.4pt 0cm 5.4pt" |  
| width="350" valign="top" style="width:262.5pt;border:solid windowtext 1.0pt; border-top:none;mso-border-top-alt:solid windowtext .5pt;mso-border-alt:solid windowtext .5pt; padding:0cm 5.4pt 0cm 5.4pt" |  
-
'''&lt;o:p&gt;&nbsp;&lt;/o:p&gt;'''
+
'''&lt;o:p&gt;&nbsp;&lt;/o:p&gt;'''  
| width="269" valign="top" style="width:201.9pt;border-top:none;border-left: none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt; mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid windowtext .5pt; mso-border-alt:solid windowtext .5pt;padding:0cm 5.4pt 0cm 5.4pt" |  
| width="269" valign="top" style="width:201.9pt;border-top:none;border-left: none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt; mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid windowtext .5pt; mso-border-alt:solid windowtext .5pt;padding:0cm 5.4pt 0cm 5.4pt" |  
-
<span style="mso-bidi-font-weight:bold">&lt;o:p&gt;&nbsp;&lt;/o:p&gt;</span>
+
<span style="mso-bidi-font-weight:bold">&lt;o:p&gt;&nbsp;&lt;/o:p&gt;</span>  
|- style="mso-yfti-irow:46"
|- style="mso-yfti-irow:46"
| width="350" valign="top" style="width:262.5pt;border:solid windowtext 1.0pt; border-top:none;mso-border-top-alt:solid windowtext .5pt;mso-border-alt:solid windowtext .5pt; padding:0cm 5.4pt 0cm 5.4pt" |  
| width="350" valign="top" style="width:262.5pt;border:solid windowtext 1.0pt; border-top:none;mso-border-top-alt:solid windowtext .5pt;mso-border-alt:solid windowtext .5pt; padding:0cm 5.4pt 0cm 5.4pt" |  
-
'''&lt;a'''
+
'''&lt;a'''  
-
'''href="http://www.nvhb.nl/richtlijnhiv/extensions/FCKeditor/fckeditor/editor/Hoofdstuk%209.%20Bijzondere%20omstandigheden"&gt;Hoofdstuk'''
+
'''href="http://www.nvhb.nl/richtlijnhiv/extensions/FCKeditor/fckeditor/editor/Hoofdstuk%209.%20Bijzondere%20omstandigheden"&gt;Hoofdstuk''' '''9. Bijzondere omstandigheden&lt;/a&gt;&lt;o:p&gt;&lt;/o:p&gt;'''  
-
'''9. Bijzondere omstandigheden&lt;/a&gt;&lt;o:p&gt;&lt;/o:p&gt;'''
+
 +
<br>
| width="269" valign="top" style="width:201.9pt;border-top:none;border-left: none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt; mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid windowtext .5pt; mso-border-alt:solid windowtext .5pt;padding:0cm 5.4pt 0cm 5.4pt" |  
| width="269" valign="top" style="width:201.9pt;border-top:none;border-left: none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt; mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid windowtext .5pt; mso-border-alt:solid windowtext .5pt;padding:0cm 5.4pt 0cm 5.4pt" |  
-
<span style="mso-bidi-font-weight:bold">&lt;o:p&gt;&nbsp;&lt;/o:p&gt;</span>
+
<span style="mso-bidi-font-weight:bold">&lt;o:p&gt;&nbsp;&lt;/o:p&gt;</span>  
|- style="mso-yfti-irow:47"
|- style="mso-yfti-irow:47"
Regel 483: Regel 485:
&lt;a  
&lt;a  
-
href="http://www.nvhb.nl/richtlijnhiv/extensions/FCKeditor/fckeditor/editor/9.1.%20Adviezen%20m.b.t.%20inname%20van%20anti-HIV%20middelen%20na%20braken"&gt;9.1.  
+
href="http://www.nvhb.nl/richtlijnhiv/extensions/FCKeditor/fckeditor/editor/9.1.%20Adviezen%20m.b.t.%20inname%20van%20anti-HIV%20middelen%20na%20braken"&gt;9.1. Adviezen m.b.t. inname van anti-HIV middelen na braken&lt;/a&gt;  
-
Adviezen m.b.t. inname van anti-HIV middelen na braken&lt;/a&gt;
+
 +
<br>
| width="269" valign="top" style="width:201.9pt;border-top:none;border-left: none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt; mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid windowtext .5pt; mso-border-alt:solid windowtext .5pt;padding:0cm 5.4pt 0cm 5.4pt" |  
| width="269" valign="top" style="width:201.9pt;border-top:none;border-left: none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt; mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid windowtext .5pt; mso-border-alt:solid windowtext .5pt;padding:0cm 5.4pt 0cm 5.4pt" |  
-
&lt;o:p&gt;&nbsp;&lt;/o:p&gt;
+
&lt;o:p&gt;&nbsp;&lt;/o:p&gt;  
|- style="mso-yfti-irow:48"
|- style="mso-yfti-irow:48"
Regel 494: Regel 496:
&lt;a  
&lt;a  
-
href="http://www.nvhb.nl/richtlijnhiv/extensions/FCKeditor/fckeditor/editor/9.2.%20Adviezen%20m.b.t.%20inname%20van%20anti-HIV%20middelen%20bij%20vergeten%20van%20slikmoment"&gt;9.2.  
+
href="http://www.nvhb.nl/richtlijnhiv/extensions/FCKeditor/fckeditor/editor/9.2.%20Adviezen%20m.b.t.%20inname%20van%20anti-HIV%20middelen%20bij%20vergeten%20van%20slikmoment"&gt;9.2. Adviezen m.b.t. inname van anti-HIV middelen bij vergeten van slikmoment&lt;/a&gt;  
-
Adviezen m.b.t. inname van anti-HIV middelen bij vergeten van slikmoment&lt;/a&gt;
+
 +
<br>
| width="269" valign="top" style="width:201.9pt;border-top:none;border-left: none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt; mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid windowtext .5pt; mso-border-alt:solid windowtext .5pt;padding:0cm 5.4pt 0cm 5.4pt" |  
| width="269" valign="top" style="width:201.9pt;border-top:none;border-left: none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt; mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid windowtext .5pt; mso-border-alt:solid windowtext .5pt;padding:0cm 5.4pt 0cm 5.4pt" |  
-
&lt;o:p&gt;&nbsp;&lt;/o:p&gt;
+
&lt;o:p&gt;&nbsp;&lt;/o:p&gt;  
|- style="mso-yfti-irow:49"
|- style="mso-yfti-irow:49"
Regel 505: Regel 507:
&lt;a  
&lt;a  
-
href="http://www.nvhb.nl/richtlijnhiv/extensions/FCKeditor/fckeditor/editor/9.3.%20Marge%20tussen%20twee%20innames"&gt;9.3.  
+
href="http://www.nvhb.nl/richtlijnhiv/extensions/FCKeditor/fckeditor/editor/9.3.%20Marge%20tussen%20twee%20innames"&gt;9.3. Marge tussen twee innames&lt;/a&gt;  
-
Marge tussen twee innames&lt;/a&gt;
+
 +
<br>
| width="269" valign="top" style="width:201.9pt;border-top:none;border-left: none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt; mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid windowtext .5pt; mso-border-alt:solid windowtext .5pt;padding:0cm 5.4pt 0cm 5.4pt" |  
| width="269" valign="top" style="width:201.9pt;border-top:none;border-left: none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt; mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid windowtext .5pt; mso-border-alt:solid windowtext .5pt;padding:0cm 5.4pt 0cm 5.4pt" |  
-
&lt;o:p&gt;&nbsp;&lt;/o:p&gt;
+
&lt;o:p&gt;&nbsp;&lt;/o:p&gt;  
|- style="mso-yfti-irow:50"
|- style="mso-yfti-irow:50"
Regel 516: Regel 518:
&lt;a  
&lt;a  
-
href="http://www.nvhb.nl/richtlijnhiv/extensions/FCKeditor/fckeditor/editor/9.4.%20Inname%20medicatie%20bij%20overschrijden%20tijdzones"&gt;9.4.  
+
href="http://www.nvhb.nl/richtlijnhiv/extensions/FCKeditor/fckeditor/editor/9.4.%20Inname%20medicatie%20bij%20overschrijden%20tijdzones"&gt;9.4. Inname medicatie bij overschrijden tijdzones&lt;/a&gt;  
-
Inname medicatie bij overschrijden tijdzones&lt;/a&gt;
+
 +
<br>
| width="269" valign="top" style="width:201.9pt;border-top:none;border-left: none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt; mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid windowtext .5pt; mso-border-alt:solid windowtext .5pt;padding:0cm 5.4pt 0cm 5.4pt" |  
| width="269" valign="top" style="width:201.9pt;border-top:none;border-left: none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt; mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid windowtext .5pt; mso-border-alt:solid windowtext .5pt;padding:0cm 5.4pt 0cm 5.4pt" |  
-
&lt;o:p&gt;&nbsp;&lt;/o:p&gt;
+
&lt;o:p&gt;&nbsp;&lt;/o:p&gt;  
|- style="mso-yfti-irow:51"
|- style="mso-yfti-irow:51"
Regel 527: Regel 529:
&lt;a  
&lt;a  
-
href="http://www.nvhb.nl/richtlijnhiv/extensions/FCKeditor/fckeditor/editor/9.5.%20Adviezen%20m.b.t.%20gebruik%20anti-HIV%20middelen%20door%20de%20sonde"&gt;9.5.  
+
href="http://www.nvhb.nl/richtlijnhiv/extensions/FCKeditor/fckeditor/editor/9.5.%20Adviezen%20m.b.t.%20gebruik%20anti-HIV%20middelen%20door%20de%20sonde"&gt;9.5. Adviezen m.b.t. gebruik anti-HIV middelen door de sonde&lt;/a&gt;  
-
Adviezen m.b.t. gebruik anti-HIV middelen door de sonde&lt;/a&gt;
+
 +
<br>
| width="269" valign="top" style="width:201.9pt;border-top:none;border-left: none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt; mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid windowtext .5pt; mso-border-alt:solid windowtext .5pt;padding:0cm 5.4pt 0cm 5.4pt" |  
| width="269" valign="top" style="width:201.9pt;border-top:none;border-left: none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt; mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid windowtext .5pt; mso-border-alt:solid windowtext .5pt;padding:0cm 5.4pt 0cm 5.4pt" |  
-
&lt;o:p&gt;&nbsp;&lt;/o:p&gt;
+
&lt;o:p&gt;&nbsp;&lt;/o:p&gt;  
|- style="mso-yfti-irow:52"
|- style="mso-yfti-irow:52"
Regel 538: Regel 540:
&lt;a  
&lt;a  
-
href="http://www.nvhb.nl/richtlijnhiv/extensions/FCKeditor/fckeditor/editor/9.6.%20Doseringen%20bij%20gestoorde%20lever-%20en%20nierfunctie"&gt;9.6.  
+
href="http://www.nvhb.nl/richtlijnhiv/extensions/FCKeditor/fckeditor/editor/9.6.%20Doseringen%20bij%20gestoorde%20lever-%20en%20nierfunctie"&gt;9.6. Doseringen bij gestoorde lever- en nierfunctie&lt;/a&gt;  
-
Doseringen bij gestoorde lever- en nierfunctie&lt;/a&gt;
+
 +
<br>
| width="269" valign="top" style="width:201.9pt;border-top:none;border-left: none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt; mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid windowtext .5pt; mso-border-alt:solid windowtext .5pt;padding:0cm 5.4pt 0cm 5.4pt" |  
| width="269" valign="top" style="width:201.9pt;border-top:none;border-left: none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt; mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid windowtext .5pt; mso-border-alt:solid windowtext .5pt;padding:0cm 5.4pt 0cm 5.4pt" |  
-
&lt;o:p&gt;&nbsp;&lt;/o:p&gt;
+
&lt;o:p&gt;&nbsp;&lt;/o:p&gt;  
|- style="mso-yfti-irow:53"
|- style="mso-yfti-irow:53"
| width="350" valign="top" style="width:262.5pt;border:solid windowtext 1.0pt; border-top:none;mso-border-top-alt:solid windowtext .5pt;mso-border-alt:solid windowtext .5pt; padding:0cm 5.4pt 0cm 5.4pt" |  
| width="350" valign="top" style="width:262.5pt;border:solid windowtext 1.0pt; border-top:none;mso-border-top-alt:solid windowtext .5pt;mso-border-alt:solid windowtext .5pt; padding:0cm 5.4pt 0cm 5.4pt" |  
-
'''&lt;o:p&gt;&nbsp;&lt;/o:p&gt;'''
+
'''&lt;o:p&gt;&nbsp;&lt;/o:p&gt;'''  
| width="269" valign="top" style="width:201.9pt;border-top:none;border-left: none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt; mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid windowtext .5pt; mso-border-alt:solid windowtext .5pt;padding:0cm 5.4pt 0cm 5.4pt" |  
| width="269" valign="top" style="width:201.9pt;border-top:none;border-left: none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt; mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid windowtext .5pt; mso-border-alt:solid windowtext .5pt;padding:0cm 5.4pt 0cm 5.4pt" |  
-
<span style="mso-bidi-font-weight:bold">&lt;o:p&gt;&nbsp;&lt;/o:p&gt;</span>
+
<span style="mso-bidi-font-weight:bold">&lt;o:p&gt;&nbsp;&lt;/o:p&gt;</span>  
|- style="mso-yfti-irow:54"
|- style="mso-yfti-irow:54"
| width="350" valign="top" style="width:262.5pt;border:solid windowtext 1.0pt; border-top:none;mso-border-top-alt:solid windowtext .5pt;mso-border-alt:solid windowtext .5pt; padding:0cm 5.4pt 0cm 5.4pt" |  
| width="350" valign="top" style="width:262.5pt;border:solid windowtext 1.0pt; border-top:none;mso-border-top-alt:solid windowtext .5pt;mso-border-alt:solid windowtext .5pt; padding:0cm 5.4pt 0cm 5.4pt" |  
-
'''&lt;a'''
+
'''&lt;a'''  
-
'''href="http://www.nvhb.nl/richtlijnhiv/extensions/FCKeditor/fckeditor/editor/Hoofdstuk%2010.%20Behandeling%20van%20hepatitis%20B/C-virus%20co%C3%AFnfectie%20bij%20HIV-1%20positieve%20pati%C3%ABnten"&gt;Hoofdstuk 10. Behandeling van hepatitis B/C-virus <span class="SpellE">coïnfectie</span>'''
+
'''href="http://www.nvhb.nl/richtlijnhiv/extensions/FCKeditor/fckeditor/editor/Hoofdstuk%2010.%20Behandeling%20van%20hepatitis%20B/C-virus%20co%C3%AFnfectie%20bij%20HIV-1%20positieve%20pati%C3%ABnten"&gt;Hoofdstuk 10. Behandeling van hepatitis B/C-virus <span class="SpellE">coïnfectie</span>''' '''bij HIV-1 positieve patiënten&lt;/a&gt;&lt;o:p&gt;&lt;/o:p&gt;'''  
-
'''bij HIV-1 positieve patiënten&lt;/a&gt;&lt;o:p&gt;&lt;/o:p&gt;'''
+
 +
<br>
| width="269" valign="top" style="width:201.9pt;border-top:none;border-left: none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt; mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid windowtext .5pt; mso-border-alt:solid windowtext .5pt;padding:0cm 5.4pt 0cm 5.4pt" |  
| width="269" valign="top" style="width:201.9pt;border-top:none;border-left: none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt; mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid windowtext .5pt; mso-border-alt:solid windowtext .5pt;padding:0cm 5.4pt 0cm 5.4pt" |  
-
<span style="mso-bidi-font-weight:bold">&lt;o:p&gt;&nbsp;&lt;/o:p&gt;</span>
+
<span style="mso-bidi-font-weight:bold">&lt;o:p&gt;&nbsp;&lt;/o:p&gt;</span>  
|- style="mso-yfti-irow:55"
|- style="mso-yfti-irow:55"
| width="350" valign="top" style="width:262.5pt;border:solid windowtext 1.0pt; border-top:none;mso-border-top-alt:solid windowtext .5pt;mso-border-alt:solid windowtext .5pt; padding:0cm 5.4pt 0cm 5.4pt" |  
| width="350" valign="top" style="width:262.5pt;border:solid windowtext 1.0pt; border-top:none;mso-border-top-alt:solid windowtext .5pt;mso-border-alt:solid windowtext .5pt; padding:0cm 5.4pt 0cm 5.4pt" |  
-
&lt;a href="http://www.nvhb.nl/richtlijnhiv/extensions/FCKeditor/fckeditor/editor/10.1.%20Hepatitis%20B"&gt;<span lang="EN-US" style="mso-ansi-language:EN-US">10.1. Hepatitis B</span>&lt;/a&gt;<span lang="EN-US" style="mso-ansi-language:EN-US">&lt;o:p&gt;&lt;/o:p&gt;</span>
+
&lt;a href="http://www.nvhb.nl/richtlijnhiv/extensions/FCKeditor/fckeditor/editor/10.1.%20Hepatitis%20B"&gt;<span lang="EN-US" style="mso-ansi-language:EN-US">10.1. Hepatitis B</span>&lt;/a&gt;<span lang="EN-US" style="mso-ansi-language:EN-US">&lt;o:p&gt;&lt;/o:p&gt;</span>  
| width="269" valign="top" style="width:201.9pt;border-top:none;border-left: none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt; mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid windowtext .5pt; mso-border-alt:solid windowtext .5pt;padding:0cm 5.4pt 0cm 5.4pt" |  
| width="269" valign="top" style="width:201.9pt;border-top:none;border-left: none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt; mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid windowtext .5pt; mso-border-alt:solid windowtext .5pt;padding:0cm 5.4pt 0cm 5.4pt" |  
-
EACS
+
EACS  
|- style="mso-yfti-irow:56"
|- style="mso-yfti-irow:56"
| width="350" valign="top" style="width:262.5pt;border:solid windowtext 1.0pt; border-top:none;mso-border-top-alt:solid windowtext .5pt;mso-border-alt:solid windowtext .5pt; padding:0cm 5.4pt 0cm 5.4pt" |  
| width="350" valign="top" style="width:262.5pt;border:solid windowtext 1.0pt; border-top:none;mso-border-top-alt:solid windowtext .5pt;mso-border-alt:solid windowtext .5pt; padding:0cm 5.4pt 0cm 5.4pt" |  
-
&lt;a href="http://www.nvhb.nl/richtlijnhiv/extensions/FCKeditor/fckeditor/editor/10.2.%20Hepatitis%20C%C2%A0%28acuut%29"&gt;<span lang="EN-US" style="mso-ansi-language:EN-US">10.2. Hepatitis C&nbsp;(<span class="SpellE">acuut</span>)</span>&lt;/a&gt;<span lang="EN-US" style="mso-ansi-language: EN-US">&lt;o:p&gt;&lt;/o:p&gt;</span>
+
&lt;a href="http://www.nvhb.nl/richtlijnhiv/extensions/FCKeditor/fckeditor/editor/10.2.%20Hepatitis%20C%C2%A0%28acuut%29"&gt;<span lang="EN-US" style="mso-ansi-language:EN-US">10.2. Hepatitis C&nbsp;(<span class="SpellE">acuut</span>)</span>&lt;/a&gt;<span lang="EN-US" style="mso-ansi-language: EN-US">&lt;o:p&gt;&lt;/o:p&gt;</span>  
| width="269" valign="top" style="width:201.9pt;border-top:none;border-left: none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt; mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid windowtext .5pt; mso-border-alt:solid windowtext .5pt;padding:0cm 5.4pt 0cm 5.4pt" |  
| width="269" valign="top" style="width:201.9pt;border-top:none;border-left: none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt; mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid windowtext .5pt; mso-border-alt:solid windowtext .5pt;padding:0cm 5.4pt 0cm 5.4pt" |  
-
NL aanbevelingen
+
NL aanbevelingen  
-
NEAT
+
NEAT  
|- style="mso-yfti-irow:57"
|- style="mso-yfti-irow:57"
| width="350" valign="top" style="width:262.5pt;border:solid windowtext 1.0pt; border-top:none;mso-border-top-alt:solid windowtext .5pt;mso-border-alt:solid windowtext .5pt; padding:0cm 5.4pt 0cm 5.4pt" |  
| width="350" valign="top" style="width:262.5pt;border:solid windowtext 1.0pt; border-top:none;mso-border-top-alt:solid windowtext .5pt;mso-border-alt:solid windowtext .5pt; padding:0cm 5.4pt 0cm 5.4pt" |  
-
&lt;a href="http://www.nvhb.nl/richtlijnhiv/extensions/FCKeditor/fckeditor/editor/Levels%20of%20evidence"&gt;<span lang="EN-US" style="mso-ansi-language:EN-US">Levels of evidence</span>&lt;/a&gt;<span lang="EN-US" style="mso-ansi-language:EN-US">&lt;o:p&gt;&lt;/o:p&gt;</span>
+
&lt;a href="http://www.nvhb.nl/richtlijnhiv/extensions/FCKeditor/fckeditor/editor/Levels%20of%20evidence"&gt;<span lang="EN-US" style="mso-ansi-language:EN-US">Levels of evidence</span>&lt;/a&gt;<span lang="EN-US" style="mso-ansi-language:EN-US">&lt;o:p&gt;&lt;/o:p&gt;</span>  
| width="269" valign="top" style="width:201.9pt;border-top:none;border-left: none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt; mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid windowtext .5pt; mso-border-alt:solid windowtext .5pt;padding:0cm 5.4pt 0cm 5.4pt" |  
| width="269" valign="top" style="width:201.9pt;border-top:none;border-left: none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt; mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid windowtext .5pt; mso-border-alt:solid windowtext .5pt;padding:0cm 5.4pt 0cm 5.4pt" |  
-
&lt;o:p&gt;&nbsp;&lt;/o:p&gt;
+
&lt;o:p&gt;&nbsp;&lt;/o:p&gt;  
|- style="mso-yfti-irow:58"
|- style="mso-yfti-irow:58"
Regel 590: Regel 592:
&lt;a  
&lt;a  
-
href="http://www.nvhb.nl/richtlijnhiv/extensions/FCKeditor/fckeditor/editor/Literatuur%2010.2"&gt;Literatuur  
+
href="http://www.nvhb.nl/richtlijnhiv/extensions/FCKeditor/fckeditor/editor/Literatuur%2010.2"&gt;Literatuur 10.2&lt;/a&gt;  
-
10.2&lt;/a&gt;
+
 +
<br>
| width="269" valign="top" style="width:201.9pt;border-top:none;border-left: none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt; mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid windowtext .5pt; mso-border-alt:solid windowtext .5pt;padding:0cm 5.4pt 0cm 5.4pt" |  
| width="269" valign="top" style="width:201.9pt;border-top:none;border-left: none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt; mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid windowtext .5pt; mso-border-alt:solid windowtext .5pt;padding:0cm 5.4pt 0cm 5.4pt" |  
-
&lt;o:p&gt;&nbsp;&lt;/o:p&gt;
+
&lt;o:p&gt;&nbsp;&lt;/o:p&gt;  
|- style="mso-yfti-irow:59"
|- style="mso-yfti-irow:59"
Regel 601: Regel 603:
&lt;a  
&lt;a  
-
href="http://www.nvhb.nl/richtlijnhiv/extensions/FCKeditor/fckeditor/editor/10.3.%20Hepatitis%20C%C2%A0%28chronisch%29"&gt;10.3.  
+
href="http://www.nvhb.nl/richtlijnhiv/extensions/FCKeditor/fckeditor/editor/10.3.%20Hepatitis%20C%C2%A0%28chronisch%29"&gt;10.3. Hepatitis C&nbsp;(chronisch)&lt;/a&gt;  
-
Hepatitis C&nbsp;(chronisch)&lt;/a&gt;
+
 +
<br>
| width="269" valign="top" style="width:201.9pt;border-top:none;border-left: none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt; mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid windowtext .5pt; mso-border-alt:solid windowtext .5pt;padding:0cm 5.4pt 0cm 5.4pt" |  
| width="269" valign="top" style="width:201.9pt;border-top:none;border-left: none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt; mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid windowtext .5pt; mso-border-alt:solid windowtext .5pt;padding:0cm 5.4pt 0cm 5.4pt" |  
-
EACS
+
EACS  
|- style="mso-yfti-irow:60"
|- style="mso-yfti-irow:60"
| width="350" valign="top" style="width:262.5pt;border:solid windowtext 1.0pt; border-top:none;mso-border-top-alt:solid windowtext .5pt;mso-border-alt:solid windowtext .5pt; padding:0cm 5.4pt 0cm 5.4pt" |  
| width="350" valign="top" style="width:262.5pt;border:solid windowtext 1.0pt; border-top:none;mso-border-top-alt:solid windowtext .5pt;mso-border-alt:solid windowtext .5pt; padding:0cm 5.4pt 0cm 5.4pt" |  
-
&lt;o:p&gt;&nbsp;&lt;/o:p&gt;
+
&lt;o:p&gt;&nbsp;&lt;/o:p&gt;  
| width="269" valign="top" style="width:201.9pt;border-top:none;border-left: none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt; mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid windowtext .5pt; mso-border-alt:solid windowtext .5pt;padding:0cm 5.4pt 0cm 5.4pt" |  
| width="269" valign="top" style="width:201.9pt;border-top:none;border-left: none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt; mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid windowtext .5pt; mso-border-alt:solid windowtext .5pt;padding:0cm 5.4pt 0cm 5.4pt" |  
-
&lt;o:p&gt;&nbsp;&lt;/o:p&gt;
+
&lt;o:p&gt;&nbsp;&lt;/o:p&gt;  
|- style="mso-yfti-irow:61"
|- style="mso-yfti-irow:61"
| width="350" valign="top" style="width:262.5pt;border:solid windowtext 1.0pt; border-top:none;mso-border-top-alt:solid windowtext .5pt;mso-border-alt:solid windowtext .5pt; padding:0cm 5.4pt 0cm 5.4pt" |  
| width="350" valign="top" style="width:262.5pt;border:solid windowtext 1.0pt; border-top:none;mso-border-top-alt:solid windowtext .5pt;mso-border-alt:solid windowtext .5pt; padding:0cm 5.4pt 0cm 5.4pt" |  
-
'''&lt;a'''
+
'''&lt;a'''  
-
'''href="http://www.nvhb.nl/richtlijnhiv/extensions/FCKeditor/fckeditor/editor/Hoofdstuk%2011.%20Behandeling%20van%20tuberculose%20bij%20pati%C3%ABnten%20met%20een%20HIV-infectie"&gt;Hoofdstuk'''
+
'''href="http://www.nvhb.nl/richtlijnhiv/extensions/FCKeditor/fckeditor/editor/Hoofdstuk%2011.%20Behandeling%20van%20tuberculose%20bij%20pati%C3%ABnten%20met%20een%20HIV-infectie"&gt;Hoofdstuk''' '''11. Behandeling van tuberculose bij patiënten met een HIV-<span class="SpellE">infectie</span>&lt;/a&gt;&lt;o:p&gt;&lt;/o:p&gt;'''  
-
'''11. Behandeling van tuberculose bij patiënten met een HIV-<span class="SpellE">infectie</span>&lt;/a&gt;&lt;o:p&gt;&lt;/o:p&gt;'''
+
 +
<br>
| width="269" valign="top" style="width:201.9pt;border-top:none;border-left: none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt; mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid windowtext .5pt; mso-border-alt:solid windowtext .5pt;padding:0cm 5.4pt 0cm 5.4pt" |  
| width="269" valign="top" style="width:201.9pt;border-top:none;border-left: none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt; mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid windowtext .5pt; mso-border-alt:solid windowtext .5pt;padding:0cm 5.4pt 0cm 5.4pt" |  
-
<span style="mso-bidi-font-weight:bold">CBO Tuberculose-HIV&lt;o:p&gt;&lt;/o:p&gt;</span>
+
<span style="mso-bidi-font-weight:bold">CBO Tuberculose-HIV&lt;o:p&gt;&lt;/o:p&gt;</span>  
|- style="mso-yfti-irow:62"
|- style="mso-yfti-irow:62"
Regel 630: Regel 632:
&lt;a  
&lt;a  
-
href="http://www.nvhb.nl/richtlijnhiv/extensions/FCKeditor/fckeditor/editor/Literatuur%2011"&gt;Literatuur  
+
href="http://www.nvhb.nl/richtlijnhiv/extensions/FCKeditor/fckeditor/editor/Literatuur%2011"&gt;Literatuur 11&lt;/a&gt;  
-
11&lt;/a&gt;
+
 +
<br>
| width="269" valign="top" style="width:201.9pt;border-top:none;border-left: none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt; mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid windowtext .5pt; mso-border-alt:solid windowtext .5pt;padding:0cm 5.4pt 0cm 5.4pt" |  
| width="269" valign="top" style="width:201.9pt;border-top:none;border-left: none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt; mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid windowtext .5pt; mso-border-alt:solid windowtext .5pt;padding:0cm 5.4pt 0cm 5.4pt" |  
-
&lt;o:p&gt;&nbsp;&lt;/o:p&gt;
+
&lt;o:p&gt;&nbsp;&lt;/o:p&gt;  
|- style="mso-yfti-irow:63"
|- style="mso-yfti-irow:63"
| width="350" valign="top" style="width:262.5pt;border:solid windowtext 1.0pt; border-top:none;mso-border-top-alt:solid windowtext .5pt;mso-border-alt:solid windowtext .5pt; padding:0cm 5.4pt 0cm 5.4pt" |  
| width="350" valign="top" style="width:262.5pt;border:solid windowtext 1.0pt; border-top:none;mso-border-top-alt:solid windowtext .5pt;mso-border-alt:solid windowtext .5pt; padding:0cm 5.4pt 0cm 5.4pt" |  
-
&lt;o:p&gt;&nbsp;&lt;/o:p&gt;
+
&lt;o:p&gt;&nbsp;&lt;/o:p&gt;  
| width="269" valign="top" style="width:201.9pt;border-top:none;border-left: none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt; mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid windowtext .5pt; mso-border-alt:solid windowtext .5pt;padding:0cm 5.4pt 0cm 5.4pt" |  
| width="269" valign="top" style="width:201.9pt;border-top:none;border-left: none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt; mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid windowtext .5pt; mso-border-alt:solid windowtext .5pt;padding:0cm 5.4pt 0cm 5.4pt" |  
-
&lt;o:p&gt;&nbsp;&lt;/o:p&gt;
+
&lt;o:p&gt;&nbsp;&lt;/o:p&gt;  
|- style="mso-yfti-irow:64"
|- style="mso-yfti-irow:64"
| width="350" valign="top" style="width:262.5pt;border:solid windowtext 1.0pt; border-top:none;mso-border-top-alt:solid windowtext .5pt;mso-border-alt:solid windowtext .5pt; padding:0cm 5.4pt 0cm 5.4pt" |  
| width="350" valign="top" style="width:262.5pt;border:solid windowtext 1.0pt; border-top:none;mso-border-top-alt:solid windowtext .5pt;mso-border-alt:solid windowtext .5pt; padding:0cm 5.4pt 0cm 5.4pt" |  
-
'''&lt;a'''
+
'''&lt;a'''  
-
'''href="http://www.nvhb.nl/richtlijnhiv/extensions/FCKeditor/fckeditor/editor/Hoofdstuk%2012.%20Comorbiditeit%20en%20bijwerkingen"&gt;Hoofdstuk'''
+
'''href="http://www.nvhb.nl/richtlijnhiv/extensions/FCKeditor/fckeditor/editor/Hoofdstuk%2012.%20Comorbiditeit%20en%20bijwerkingen"&gt;Hoofdstuk''' '''12. Comorbiditeit en bijwerkingen&lt;/a&gt;&lt;o:p&gt;&lt;/o:p&gt;'''  
-
'''12. Comorbiditeit en bijwerkingen&lt;/a&gt;&lt;o:p&gt;&lt;/o:p&gt;'''
+
 +
<br>
| width="269" valign="top" style="width:201.9pt;border-top:none;border-left: none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt; mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid windowtext .5pt; mso-border-alt:solid windowtext .5pt;padding:0cm 5.4pt 0cm 5.4pt" |  
| width="269" valign="top" style="width:201.9pt;border-top:none;border-left: none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt; mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid windowtext .5pt; mso-border-alt:solid windowtext .5pt;padding:0cm 5.4pt 0cm 5.4pt" |  
-
<span style="mso-bidi-font-weight:bold">EACS&lt;o:p&gt;&lt;/o:p&gt;</span>
+
<span style="mso-bidi-font-weight:bold">EACS&lt;o:p&gt;&lt;/o:p&gt;</span>  
|- style="mso-yfti-irow:65"
|- style="mso-yfti-irow:65"
| width="350" valign="top" style="width:262.5pt;border:solid windowtext 1.0pt; border-top:none;mso-border-top-alt:solid windowtext .5pt;mso-border-alt:solid windowtext .5pt; padding:0cm 5.4pt 0cm 5.4pt" |  
| width="350" valign="top" style="width:262.5pt;border:solid windowtext 1.0pt; border-top:none;mso-border-top-alt:solid windowtext .5pt;mso-border-alt:solid windowtext .5pt; padding:0cm 5.4pt 0cm 5.4pt" |  
-
'''&lt;o:p&gt;&nbsp;&lt;/o:p&gt;'''
+
'''&lt;o:p&gt;&nbsp;&lt;/o:p&gt;'''  
| width="269" valign="top" style="width:201.9pt;border-top:none;border-left: none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt; mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid windowtext .5pt; mso-border-alt:solid windowtext .5pt;padding:0cm 5.4pt 0cm 5.4pt" |  
| width="269" valign="top" style="width:201.9pt;border-top:none;border-left: none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt; mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid windowtext .5pt; mso-border-alt:solid windowtext .5pt;padding:0cm 5.4pt 0cm 5.4pt" |  
-
<span style="mso-bidi-font-weight:bold">&lt;o:p&gt;&nbsp;&lt;/o:p&gt;</span>
+
<span style="mso-bidi-font-weight:bold">&lt;o:p&gt;&nbsp;&lt;/o:p&gt;</span>  
|- style="mso-yfti-irow:66"
|- style="mso-yfti-irow:66"
| width="350" valign="top" style="width:262.5pt;border:solid windowtext 1.0pt; border-top:none;mso-border-top-alt:solid windowtext .5pt;mso-border-alt:solid windowtext .5pt; padding:0cm 5.4pt 0cm 5.4pt" |  
| width="350" valign="top" style="width:262.5pt;border:solid windowtext 1.0pt; border-top:none;mso-border-top-alt:solid windowtext .5pt;mso-border-alt:solid windowtext .5pt; padding:0cm 5.4pt 0cm 5.4pt" |  
-
'''&lt;a'''
+
'''&lt;a'''  
-
'''href="http://www.nvhb.nl/richtlijnhiv/extensions/FCKeditor/fckeditor/editor/Hoofdstuk%2013.%20Screening%20van%20HIV-pati%C3%ABnten%20op%20anogenitale%20maligniteiten"&gt;Hoofdstuk'''
+
'''href="http://www.nvhb.nl/richtlijnhiv/extensions/FCKeditor/fckeditor/editor/Hoofdstuk%2013.%20Screening%20van%20HIV-pati%C3%ABnten%20op%20anogenitale%20maligniteiten"&gt;Hoofdstuk''' '''13. Screening van HIV-patiënten op anogenitale maligniteiten&lt;/a&gt;&lt;o:p&gt;&lt;/o:p&gt;'''  
-
'''13. Screening van HIV-patiënten op anogenitale maligniteiten&lt;/a&gt;&lt;o:p&gt;&lt;/o:p&gt;'''
+
 +
<br>
| width="269" valign="top" style="width:201.9pt;border-top:none;border-left: none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt; mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid windowtext .5pt; mso-border-alt:solid windowtext .5pt;padding:0cm 5.4pt 0cm 5.4pt" |  
| width="269" valign="top" style="width:201.9pt;border-top:none;border-left: none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt; mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid windowtext .5pt; mso-border-alt:solid windowtext .5pt;padding:0cm 5.4pt 0cm 5.4pt" |  
-
<span style="mso-bidi-font-weight:bold">&lt;o:p&gt;&nbsp;&lt;/o:p&gt;</span>
+
<span style="mso-bidi-font-weight:bold">&lt;o:p&gt;&nbsp;&lt;/o:p&gt;</span>  
|- style="mso-yfti-irow:67"
|- style="mso-yfti-irow:67"
Regel 677: Regel 679:
&lt;a  
&lt;a  
-
href="http://www.nvhb.nl/richtlijnhiv/extensions/FCKeditor/fckeditor/editor/Onderbouwing%20screening%20van%20HIV-pati%C3%ABnten%20op%20anogenitale%20maligniteiten"&gt;Onderbouwing  
+
href="http://www.nvhb.nl/richtlijnhiv/extensions/FCKeditor/fckeditor/editor/Onderbouwing%20screening%20van%20HIV-pati%C3%ABnten%20op%20anogenitale%20maligniteiten"&gt;Onderbouwing screening van HIV-patiënten op anogenitale maligniteiten&lt;/a&gt;  
-
screening van HIV-patiënten op anogenitale maligniteiten&lt;/a&gt;
+
 +
<br>
| width="269" valign="top" style="width:201.9pt;border-top:none;border-left: none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt; mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid windowtext .5pt; mso-border-alt:solid windowtext .5pt;padding:0cm 5.4pt 0cm 5.4pt" |  
| width="269" valign="top" style="width:201.9pt;border-top:none;border-left: none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt; mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid windowtext .5pt; mso-border-alt:solid windowtext .5pt;padding:0cm 5.4pt 0cm 5.4pt" |  
-
&lt;o:p&gt;&nbsp;&lt;/o:p&gt;
+
&lt;o:p&gt;&nbsp;&lt;/o:p&gt;  
|- style="mso-yfti-irow:68"
|- style="mso-yfti-irow:68"
Regel 688: Regel 690:
&lt;a  
&lt;a  
-
href="http://www.nvhb.nl/richtlijnhiv/extensions/FCKeditor/fckeditor/editor/Literatuur%2013"&gt;Literatuur  
+
href="http://www.nvhb.nl/richtlijnhiv/extensions/FCKeditor/fckeditor/editor/Literatuur%2013"&gt;Literatuur 13&lt;/a&gt;  
-
13&lt;/a&gt;
+
 +
<br>
| width="269" valign="top" style="width:201.9pt;border-top:none;border-left: none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt; mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid windowtext .5pt; mso-border-alt:solid windowtext .5pt;padding:0cm 5.4pt 0cm 5.4pt" |  
| width="269" valign="top" style="width:201.9pt;border-top:none;border-left: none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt; mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid windowtext .5pt; mso-border-alt:solid windowtext .5pt;padding:0cm 5.4pt 0cm 5.4pt" |  
-
&lt;o:p&gt;&nbsp;&lt;/o:p&gt;
+
&lt;o:p&gt;&nbsp;&lt;/o:p&gt;  
|- style="mso-yfti-irow:69"
|- style="mso-yfti-irow:69"
| width="350" valign="top" style="width:262.5pt;border:solid windowtext 1.0pt; border-top:none;mso-border-top-alt:solid windowtext .5pt;mso-border-alt:solid windowtext .5pt; padding:0cm 5.4pt 0cm 5.4pt" |  
| width="350" valign="top" style="width:262.5pt;border:solid windowtext 1.0pt; border-top:none;mso-border-top-alt:solid windowtext .5pt;mso-border-alt:solid windowtext .5pt; padding:0cm 5.4pt 0cm 5.4pt" |  
-
'''&lt;o:p&gt;&nbsp;&lt;/o:p&gt;'''
+
'''&lt;o:p&gt;&nbsp;&lt;/o:p&gt;'''  
| width="269" valign="top" style="width:201.9pt;border-top:none;border-left: none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt; mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid windowtext .5pt; mso-border-alt:solid windowtext .5pt;padding:0cm 5.4pt 0cm 5.4pt" |  
| width="269" valign="top" style="width:201.9pt;border-top:none;border-left: none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt; mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid windowtext .5pt; mso-border-alt:solid windowtext .5pt;padding:0cm 5.4pt 0cm 5.4pt" |  
-
<span style="mso-bidi-font-weight:bold">&lt;o:p&gt;&nbsp;&lt;/o:p&gt;</span>
+
<span style="mso-bidi-font-weight:bold">&lt;o:p&gt;&nbsp;&lt;/o:p&gt;</span>  
|- style="mso-yfti-irow:70"
|- style="mso-yfti-irow:70"
| width="350" valign="top" style="width:262.5pt;border:solid windowtext 1.0pt; border-top:none;mso-border-top-alt:solid windowtext .5pt;mso-border-alt:solid windowtext .5pt; padding:0cm 5.4pt 0cm 5.4pt" |  
| width="350" valign="top" style="width:262.5pt;border:solid windowtext 1.0pt; border-top:none;mso-border-top-alt:solid windowtext .5pt;mso-border-alt:solid windowtext .5pt; padding:0cm 5.4pt 0cm 5.4pt" |  
-
'''&lt;a'''
+
'''&lt;a'''  
-
'''href="http://www.nvhb.nl/richtlijnhiv/extensions/FCKeditor/fckeditor/editor/Hoofdstuk%2014.%20Interacties"&gt;Hoofdstuk'''
+
'''href="http://www.nvhb.nl/richtlijnhiv/extensions/FCKeditor/fckeditor/editor/Hoofdstuk%2014.%20Interacties"&gt;Hoofdstuk''' '''14. Interacties&lt;/a&gt;&lt;o:p&gt;&lt;/o:p&gt;'''  
-
'''14. Interacties&lt;/a&gt;&lt;o:p&gt;&lt;/o:p&gt;'''
+
 +
<br>
| width="269" valign="top" style="width:201.9pt;border-top:none;border-left: none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt; mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid windowtext .5pt; mso-border-alt:solid windowtext .5pt;padding:0cm 5.4pt 0cm 5.4pt" |  
| width="269" valign="top" style="width:201.9pt;border-top:none;border-left: none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt; mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid windowtext .5pt; mso-border-alt:solid windowtext .5pt;padding:0cm 5.4pt 0cm 5.4pt" |  
-
<span style="mso-bidi-font-weight:bold">&lt;o:p&gt;&nbsp;&lt;/o:p&gt;</span>
+
<span style="mso-bidi-font-weight:bold">&lt;o:p&gt;&nbsp;&lt;/o:p&gt;</span>  
|- style="mso-yfti-irow:71"
|- style="mso-yfti-irow:71"
| width="350" valign="top" style="width:262.5pt;border:solid windowtext 1.0pt; border-top:none;mso-border-top-alt:solid windowtext .5pt;mso-border-alt:solid windowtext .5pt; padding:0cm 5.4pt 0cm 5.4pt" |  
| width="350" valign="top" style="width:262.5pt;border:solid windowtext 1.0pt; border-top:none;mso-border-top-alt:solid windowtext .5pt;mso-border-alt:solid windowtext .5pt; padding:0cm 5.4pt 0cm 5.4pt" |  
-
'''&lt;o:p&gt;&nbsp;&lt;/o:p&gt;'''
+
'''&lt;o:p&gt;&nbsp;&lt;/o:p&gt;'''  
| width="269" valign="top" style="width:201.9pt;border-top:none;border-left: none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt; mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid windowtext .5pt; mso-border-alt:solid windowtext .5pt;padding:0cm 5.4pt 0cm 5.4pt" |  
| width="269" valign="top" style="width:201.9pt;border-top:none;border-left: none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt; mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid windowtext .5pt; mso-border-alt:solid windowtext .5pt;padding:0cm 5.4pt 0cm 5.4pt" |  
-
<span style="mso-bidi-font-weight:bold">&lt;o:p&gt;&nbsp;&lt;/o:p&gt;</span>
+
<span style="mso-bidi-font-weight:bold">&lt;o:p&gt;&nbsp;&lt;/o:p&gt;</span>  
|- style="mso-yfti-irow:72"
|- style="mso-yfti-irow:72"
| width="350" valign="top" style="width:262.5pt;border:solid windowtext 1.0pt; border-top:none;mso-border-top-alt:solid windowtext .5pt;mso-border-alt:solid windowtext .5pt; padding:0cm 5.4pt 0cm 5.4pt" |  
| width="350" valign="top" style="width:262.5pt;border:solid windowtext 1.0pt; border-top:none;mso-border-top-alt:solid windowtext .5pt;mso-border-alt:solid windowtext .5pt; padding:0cm 5.4pt 0cm 5.4pt" |  
-
'''&lt;a'''
+
'''&lt;a'''  
-
'''href="http://www.nvhb.nl/richtlijnhiv/extensions/FCKeditor/fckeditor/editor/Hoofdstuk%2015.%20Profylaxe%20en%20behandeling%20van%20opportunistische%20infectie"&gt;Hoofdstuk'''
+
'''href="http://www.nvhb.nl/richtlijnhiv/extensions/FCKeditor/fckeditor/editor/Hoofdstuk%2015.%20Profylaxe%20en%20behandeling%20van%20opportunistische%20infectie"&gt;Hoofdstuk''' '''15. Profylaxe en behandeling van opportunistische infectie&lt;/a&gt;&lt;o:p&gt;&lt;/o:p&gt;'''  
-
'''15. Profylaxe en behandeling van opportunistische infectie&lt;/a&gt;&lt;o:p&gt;&lt;/o:p&gt;'''
+
 +
<br>
| width="269" valign="top" style="width:201.9pt;border-top:none;border-left: none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt; mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid windowtext .5pt; mso-border-alt:solid windowtext .5pt;padding:0cm 5.4pt 0cm 5.4pt" |  
| width="269" valign="top" style="width:201.9pt;border-top:none;border-left: none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt; mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid windowtext .5pt; mso-border-alt:solid windowtext .5pt;padding:0cm 5.4pt 0cm 5.4pt" |  
-
<span style="mso-bidi-font-weight:bold">CDC&lt;o:p&gt;&lt;/o:p&gt;</span>
+
<span style="mso-bidi-font-weight:bold">CDC&lt;o:p&gt;&lt;/o:p&gt;</span>  
-
<span class="GramE"><span style="mso-bidi-font-weight:bold">Nationale</span></span><span style="mso-bidi-font-weight:bold"> antibioticaboekje&lt;o:p&gt;&lt;/o:p&gt;</span>
+
<span class="GramE"><span style="mso-bidi-font-weight:bold">Nationale</span></span><span style="mso-bidi-font-weight:bold"> antibioticaboekje&lt;o:p&gt;&lt;/o:p&gt;</span>  
|- style="mso-yfti-irow:73"
|- style="mso-yfti-irow:73"
| width="350" valign="top" style="width:262.5pt;border:solid windowtext 1.0pt; border-top:none;mso-border-top-alt:solid windowtext .5pt;mso-border-alt:solid windowtext .5pt; padding:0cm 5.4pt 0cm 5.4pt" |  
| width="350" valign="top" style="width:262.5pt;border:solid windowtext 1.0pt; border-top:none;mso-border-top-alt:solid windowtext .5pt;mso-border-alt:solid windowtext .5pt; padding:0cm 5.4pt 0cm 5.4pt" |  
-
&lt;o:p&gt;&nbsp;&lt;/o:p&gt;
+
&lt;o:p&gt;&nbsp;&lt;/o:p&gt;  
| width="269" valign="top" style="width:201.9pt;border-top:none;border-left: none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt; mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid windowtext .5pt; mso-border-alt:solid windowtext .5pt;padding:0cm 5.4pt 0cm 5.4pt" |  
| width="269" valign="top" style="width:201.9pt;border-top:none;border-left: none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt; mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid windowtext .5pt; mso-border-alt:solid windowtext .5pt;padding:0cm 5.4pt 0cm 5.4pt" |  
-
&lt;o:p&gt;&nbsp;&lt;/o:p&gt;
+
&lt;o:p&gt;&nbsp;&lt;/o:p&gt;  
|- style="mso-yfti-irow:74"
|- style="mso-yfti-irow:74"
| width="350" valign="top" style="width:262.5pt;border:solid windowtext 1.0pt; border-top:none;mso-border-top-alt:solid windowtext .5pt;mso-border-alt:solid windowtext .5pt; padding:0cm 5.4pt 0cm 5.4pt" |  
| width="350" valign="top" style="width:262.5pt;border:solid windowtext 1.0pt; border-top:none;mso-border-top-alt:solid windowtext .5pt;mso-border-alt:solid windowtext .5pt; padding:0cm 5.4pt 0cm 5.4pt" |  
-
Hoofdstuk 16. Post Exposure Profylaxe na prikaccident en onveilig <span class="SpellE">sexueel</span> contact
+
Hoofdstuk 16. Post Exposure Profylaxe na prikaccident en onveilig <span class="SpellE">sexueel</span> contact  
| width="269" valign="top" style="width:201.9pt;border-top:none;border-left: none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt; mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid windowtext .5pt; mso-border-alt:solid windowtext .5pt;padding:0cm 5.4pt 0cm 5.4pt" |  
| width="269" valign="top" style="width:201.9pt;border-top:none;border-left: none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt; mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid windowtext .5pt; mso-border-alt:solid windowtext .5pt;padding:0cm 5.4pt 0cm 5.4pt" |  
-
&lt;o:p&gt;&nbsp;&lt;/o:p&gt;
+
&lt;o:p&gt;&nbsp;&lt;/o:p&gt;  
|- style="mso-yfti-irow:75"
|- style="mso-yfti-irow:75"
| width="350" valign="top" style="width:262.5pt;border:solid windowtext 1.0pt; border-top:none;mso-border-top-alt:solid windowtext .5pt;mso-border-alt:solid windowtext .5pt; padding:0cm 5.4pt 0cm 5.4pt" |  
| width="350" valign="top" style="width:262.5pt;border:solid windowtext 1.0pt; border-top:none;mso-border-top-alt:solid windowtext .5pt;mso-border-alt:solid windowtext .5pt; padding:0cm 5.4pt 0cm 5.4pt" |  
-
'''&lt;a'''
+
'''&lt;a'''  
-
'''href="http://www.nvhb.nl/richtlijnhiv/extensions/FCKeditor/fckeditor/editor/Hoofdstuk%2016.%20Transmissiereductie%20%28PEP%29"&gt;Hoofdstuk'''
+
'''href="http://www.nvhb.nl/richtlijnhiv/extensions/FCKeditor/fckeditor/editor/Hoofdstuk%2016.%20Transmissiereductie%20%28PEP%29"&gt;Hoofdstuk''' '''16. <span class="GramE">Transmissiereductie</span> (PEP)&lt;/a&gt;&lt;o:p&gt;&lt;/o:p&gt;'''  
-
'''16. <span class="GramE">Transmissiereductie</span> (PEP)&lt;/a&gt;&lt;o:p&gt;&lt;/o:p&gt;'''
+
 +
<br>
| width="269" valign="top" style="width:201.9pt;border-top:none;border-left: none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt; mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid windowtext .5pt; mso-border-alt:solid windowtext .5pt;padding:0cm 5.4pt 0cm 5.4pt" |  
| width="269" valign="top" style="width:201.9pt;border-top:none;border-left: none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt; mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid windowtext .5pt; mso-border-alt:solid windowtext .5pt;padding:0cm 5.4pt 0cm 5.4pt" |  
-
<span style="mso-bidi-font-weight:bold">&lt;o:p&gt;&nbsp;&lt;/o:p&gt;</span>
+
<span style="mso-bidi-font-weight:bold">&lt;o:p&gt;&nbsp;&lt;/o:p&gt;</span>  
|- style="mso-yfti-irow:76"
|- style="mso-yfti-irow:76"
Regel 762: Regel 764:
&lt;a  
&lt;a  
-
href="http://www.nvhb.nl/richtlijnhiv/extensions/FCKeditor/fckeditor/editor/16.1.%20Prikaccidenten"&gt;16.1.  
+
href="http://www.nvhb.nl/richtlijnhiv/extensions/FCKeditor/fckeditor/editor/16.1.%20Prikaccidenten"&gt;16.1. Prikaccidenten&lt;/a&gt;  
-
Prikaccidenten&lt;/a&gt;
+
 +
<br>
| width="269" valign="top" style="width:201.9pt;border-top:none;border-left: none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt; mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid windowtext .5pt; mso-border-alt:solid windowtext .5pt;padding:0cm 5.4pt 0cm 5.4pt" |  
| width="269" valign="top" style="width:201.9pt;border-top:none;border-left: none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt; mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid windowtext .5pt; mso-border-alt:solid windowtext .5pt;padding:0cm 5.4pt 0cm 5.4pt" |  
-
LCI
+
LCI  
|- style="mso-yfti-irow:77"
|- style="mso-yfti-irow:77"
Regel 773: Regel 775:
&lt;a  
&lt;a  
-
href="http://www.nvhb.nl/richtlijnhiv/extensions/FCKeditor/fckeditor/editor/16.2.%20Seksaccidenten"&gt;16.2.  
+
href="http://www.nvhb.nl/richtlijnhiv/extensions/FCKeditor/fckeditor/editor/16.2.%20Seksaccidenten"&gt;16.2. Seksaccidenten&lt;/a&gt;  
-
Seksaccidenten&lt;/a&gt;
+
 +
<br>
| width="269" valign="top" style="width:201.9pt;border-top:none;border-left: none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt; mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid windowtext .5pt; mso-border-alt:solid windowtext .5pt;padding:0cm 5.4pt 0cm 5.4pt" |  
| width="269" valign="top" style="width:201.9pt;border-top:none;border-left: none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt; mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid windowtext .5pt; mso-border-alt:solid windowtext .5pt;padding:0cm 5.4pt 0cm 5.4pt" |  
-
LCI/RIVM
+
LCI/RIVM  
|- style="mso-yfti-irow:78"
|- style="mso-yfti-irow:78"
| width="350" valign="top" style="width:262.5pt;border:solid windowtext 1.0pt; border-top:none;mso-border-top-alt:solid windowtext .5pt;mso-border-alt:solid windowtext .5pt; padding:0cm 5.4pt 0cm 5.4pt" |  
| width="350" valign="top" style="width:262.5pt;border:solid windowtext 1.0pt; border-top:none;mso-border-top-alt:solid windowtext .5pt;mso-border-alt:solid windowtext .5pt; padding:0cm 5.4pt 0cm 5.4pt" |  
-
'''&lt;o:p&gt;&nbsp;&lt;/o:p&gt;'''
+
'''&lt;o:p&gt;&nbsp;&lt;/o:p&gt;'''  
| width="269" valign="top" style="width:201.9pt;border-top:none;border-left: none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt; mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid windowtext .5pt; mso-border-alt:solid windowtext .5pt;padding:0cm 5.4pt 0cm 5.4pt" |  
| width="269" valign="top" style="width:201.9pt;border-top:none;border-left: none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt; mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid windowtext .5pt; mso-border-alt:solid windowtext .5pt;padding:0cm 5.4pt 0cm 5.4pt" |  
-
<span style="mso-bidi-font-weight:bold">&lt;o:p&gt;&nbsp;&lt;/o:p&gt;</span>
+
<span style="mso-bidi-font-weight:bold">&lt;o:p&gt;&nbsp;&lt;/o:p&gt;</span>  
|- style="mso-yfti-irow:79"
|- style="mso-yfti-irow:79"
| width="350" valign="top" style="width:262.5pt;border:solid windowtext 1.0pt; border-top:none;mso-border-top-alt:solid windowtext .5pt;mso-border-alt:solid windowtext .5pt; padding:0cm 5.4pt 0cm 5.4pt" |  
| width="350" valign="top" style="width:262.5pt;border:solid windowtext 1.0pt; border-top:none;mso-border-top-alt:solid windowtext .5pt;mso-border-alt:solid windowtext .5pt; padding:0cm 5.4pt 0cm 5.4pt" |  
-
'''&lt;a'''
+
'''&lt;a'''  
-
'''href="http://www.nvhb.nl/richtlijnhiv/extensions/FCKeditor/fckeditor/editor/Hoofdstuk%2017.%20Vaccinatiebeleid"&gt;Hoofdstuk'''
+
'''href="http://www.nvhb.nl/richtlijnhiv/extensions/FCKeditor/fckeditor/editor/Hoofdstuk%2017.%20Vaccinatiebeleid"&gt;Hoofdstuk''' '''17. Vaccinatiebeleid&lt;/a&gt;&lt;o:p&gt;&lt;/o:p&gt;'''  
-
'''17. Vaccinatiebeleid&lt;/a&gt;&lt;o:p&gt;&lt;/o:p&gt;'''
+
 +
<br>
| width="269" valign="top" style="width:201.9pt;border-top:none;border-left: none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt; mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid windowtext .5pt; mso-border-alt:solid windowtext .5pt;padding:0cm 5.4pt 0cm 5.4pt" |  
| width="269" valign="top" style="width:201.9pt;border-top:none;border-left: none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt; mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid windowtext .5pt; mso-border-alt:solid windowtext .5pt;padding:0cm 5.4pt 0cm 5.4pt" |  
-
<span style="mso-bidi-font-weight:bold">&lt;o:p&gt;&nbsp;&lt;/o:p&gt;</span>
+
<span style="mso-bidi-font-weight:bold">&lt;o:p&gt;&nbsp;&lt;/o:p&gt;</span>  
|- style="mso-yfti-irow:80"
|- style="mso-yfti-irow:80"
Regel 802: Regel 804:
&lt;a  
&lt;a  
-
href="http://www.nvhb.nl/richtlijnhiv/extensions/FCKeditor/fckeditor/editor/17.1.%20Vaccinaties%20bij%20HIV-ge%C3%AFnfecteerde%20kinderen"&gt;17.1.  
+
href="http://www.nvhb.nl/richtlijnhiv/extensions/FCKeditor/fckeditor/editor/17.1.%20Vaccinaties%20bij%20HIV-ge%C3%AFnfecteerde%20kinderen"&gt;17.1. Vaccinaties bij <span class="SpellE">HIV-geïnfecteerde</span> kinderen&lt;/a&gt;  
-
Vaccinaties bij <span class="SpellE">HIV-geïnfecteerde</span> kinderen&lt;/a&gt;
+
 +
<br>
| width="269" valign="top" style="width:201.9pt;border-top:none;border-left: none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt; mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid windowtext .5pt; mso-border-alt:solid windowtext .5pt;padding:0cm 5.4pt 0cm 5.4pt" |  
| width="269" valign="top" style="width:201.9pt;border-top:none;border-left: none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt; mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid windowtext .5pt; mso-border-alt:solid windowtext .5pt;padding:0cm 5.4pt 0cm 5.4pt" |  
-
CDC
+
CDC  
|- style="mso-yfti-irow:81"
|- style="mso-yfti-irow:81"
Regel 813: Regel 815:
&lt;a  
&lt;a  
-
href="http://www.nvhb.nl/richtlijnhiv/extensions/FCKeditor/fckeditor/editor/17.2.%20Vaccinatie%20tegen%20influenza"&gt;17.2.  
+
href="http://www.nvhb.nl/richtlijnhiv/extensions/FCKeditor/fckeditor/editor/17.2.%20Vaccinatie%20tegen%20influenza"&gt;17.2. Vaccinatie tegen influenza&lt;/a&gt;  
-
Vaccinatie tegen influenza&lt;/a&gt;
+
 +
<br>
| width="269" valign="top" style="width:201.9pt;border-top:none;border-left: none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt; mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid windowtext .5pt; mso-border-alt:solid windowtext .5pt;padding:0cm 5.4pt 0cm 5.4pt" |  
| width="269" valign="top" style="width:201.9pt;border-top:none;border-left: none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt; mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid windowtext .5pt; mso-border-alt:solid windowtext .5pt;padding:0cm 5.4pt 0cm 5.4pt" |  
-
NHG Standaard
+
NHG Standaard  
|- style="mso-yfti-irow:82"
|- style="mso-yfti-irow:82"
Regel 824: Regel 826:
&lt;a  
&lt;a  
-
href="http://www.nvhb.nl/richtlijnhiv/extensions/FCKeditor/fckeditor/editor/Onderbouwing%20Vaccinatie%20tegen%20influenza"&gt;Onderbouwing  
+
href="http://www.nvhb.nl/richtlijnhiv/extensions/FCKeditor/fckeditor/editor/Onderbouwing%20Vaccinatie%20tegen%20influenza"&gt;Onderbouwing Vaccinatie tegen influenza&lt;/a&gt;  
-
Vaccinatie tegen influenza&lt;/a&gt;
+
 +
<br>
| width="269" valign="top" style="width:201.9pt;border-top:none;border-left: none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt; mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid windowtext .5pt; mso-border-alt:solid windowtext .5pt;padding:0cm 5.4pt 0cm 5.4pt" |  
| width="269" valign="top" style="width:201.9pt;border-top:none;border-left: none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt; mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid windowtext .5pt; mso-border-alt:solid windowtext .5pt;padding:0cm 5.4pt 0cm 5.4pt" |  
-
&lt;o:p&gt;&nbsp;&lt;/o:p&gt;
+
&lt;o:p&gt;&nbsp;&lt;/o:p&gt;  
|- style="mso-yfti-irow:83"
|- style="mso-yfti-irow:83"
Regel 835: Regel 837:
&lt;a  
&lt;a  
-
href="http://www.nvhb.nl/richtlijnhiv/extensions/FCKeditor/fckeditor/editor/Literatuur%2017.2"&gt;Literatuur  
+
href="http://www.nvhb.nl/richtlijnhiv/extensions/FCKeditor/fckeditor/editor/Literatuur%2017.2"&gt;Literatuur 17.2&lt;/a&gt;  
-
17.2&lt;/a&gt;
+
 +
<br>
| width="269" valign="top" style="width:201.9pt;border-top:none;border-left: none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt; mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid windowtext .5pt; mso-border-alt:solid windowtext .5pt;padding:0cm 5.4pt 0cm 5.4pt" |  
| width="269" valign="top" style="width:201.9pt;border-top:none;border-left: none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt; mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid windowtext .5pt; mso-border-alt:solid windowtext .5pt;padding:0cm 5.4pt 0cm 5.4pt" |  
-
&lt;o:p&gt;&nbsp;&lt;/o:p&gt;
+
&lt;o:p&gt;&nbsp;&lt;/o:p&gt;  
|- style="mso-yfti-irow:84"
|- style="mso-yfti-irow:84"
Regel 846: Regel 848:
&lt;a  
&lt;a  
-
href="http://www.nvhb.nl/richtlijnhiv/extensions/FCKeditor/fckeditor/editor/17.3.%20Vaccinatie%20tegen%20infecties%20met%20Streptococcus%20pneumoniae%20%28Pneumokokken%29"&gt;17.3.  
+
href="http://www.nvhb.nl/richtlijnhiv/extensions/FCKeditor/fckeditor/editor/17.3.%20Vaccinatie%20tegen%20infecties%20met%20Streptococcus%20pneumoniae%20%28Pneumokokken%29"&gt;17.3. Vaccinatie tegen infecties met Streptococcus pneumoniae (Pneumokokken)&lt;/a&gt;  
-
Vaccinatie tegen infecties met Streptococcus pneumoniae (Pneumokokken)&lt;/a&gt;
+
 +
<br>
| width="269" valign="top" style="width:201.9pt;border-top:none;border-left: none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt; mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid windowtext .5pt; mso-border-alt:solid windowtext .5pt;padding:0cm 5.4pt 0cm 5.4pt" |  
| width="269" valign="top" style="width:201.9pt;border-top:none;border-left: none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt; mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid windowtext .5pt; mso-border-alt:solid windowtext .5pt;padding:0cm 5.4pt 0cm 5.4pt" |  
-
&lt;o:p&gt;&nbsp;&lt;/o:p&gt;
+
&lt;o:p&gt;&nbsp;&lt;/o:p&gt;  
|- style="mso-yfti-irow:85"
|- style="mso-yfti-irow:85"
Regel 857: Regel 859:
&lt;a  
&lt;a  
-
href="http://www.nvhb.nl/richtlijnhiv/extensions/FCKeditor/fckeditor/editor/Onderbouwing%20Vaccinatie%20tegen%20infecties%20met%20Streptococcus%20pneumoniae%20%28Pneumokokken%29%20%28Pneumokokken%29"&gt;Onderbouwing Vaccinatie tegen infecties met Streptococcus pneumoniae (Pneumokokken)  
+
href="http://www.nvhb.nl/richtlijnhiv/extensions/FCKeditor/fckeditor/editor/Onderbouwing%20Vaccinatie%20tegen%20infecties%20met%20Streptococcus%20pneumoniae%20%28Pneumokokken%29%20%28Pneumokokken%29"&gt;Onderbouwing Vaccinatie tegen infecties met Streptococcus pneumoniae (Pneumokokken) (Pneumokokken)&lt;/a&gt;  
-
(Pneumokokken)&lt;/a&gt;
+
 +
<br>
| width="269" valign="top" style="width:201.9pt;border-top:none;border-left: none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt; mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid windowtext .5pt; mso-border-alt:solid windowtext .5pt;padding:0cm 5.4pt 0cm 5.4pt" |  
| width="269" valign="top" style="width:201.9pt;border-top:none;border-left: none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt; mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid windowtext .5pt; mso-border-alt:solid windowtext .5pt;padding:0cm 5.4pt 0cm 5.4pt" |  
-
&lt;o:p&gt;&nbsp;&lt;/o:p&gt;
+
&lt;o:p&gt;&nbsp;&lt;/o:p&gt;  
|- style="mso-yfti-irow:86"
|- style="mso-yfti-irow:86"
Regel 868: Regel 870:
&lt;a  
&lt;a  
-
href="http://www.nvhb.nl/richtlijnhiv/extensions/FCKeditor/fckeditor/editor/Literatuur%2017.3"&gt;Literatuur  
+
href="http://www.nvhb.nl/richtlijnhiv/extensions/FCKeditor/fckeditor/editor/Literatuur%2017.3"&gt;Literatuur 17.3&lt;/a&gt;  
-
17.3&lt;/a&gt;
+
 +
<br>
| width="269" valign="top" style="width:201.9pt;border-top:none;border-left: none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt; mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid windowtext .5pt; mso-border-alt:solid windowtext .5pt;padding:0cm 5.4pt 0cm 5.4pt" |  
| width="269" valign="top" style="width:201.9pt;border-top:none;border-left: none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt; mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid windowtext .5pt; mso-border-alt:solid windowtext .5pt;padding:0cm 5.4pt 0cm 5.4pt" |  
-
&lt;o:p&gt;&nbsp;&lt;/o:p&gt;
+
&lt;o:p&gt;&nbsp;&lt;/o:p&gt;  
|- style="mso-yfti-irow:87"
|- style="mso-yfti-irow:87"
Regel 879: Regel 881:
&lt;a  
&lt;a  
-
href="http://www.nvhb.nl/richtlijnhiv/extensions/FCKeditor/fckeditor/editor/17.4.%20Vaccinaties%20tegen%20Hepatitis%20A%20en%20B"&gt;17.4.  
+
href="http://www.nvhb.nl/richtlijnhiv/extensions/FCKeditor/fckeditor/editor/17.4.%20Vaccinaties%20tegen%20Hepatitis%20A%20en%20B"&gt;17.4. Vaccinaties tegen Hepatitis A en B&lt;/a&gt;  
-
Vaccinaties tegen Hepatitis A en B&lt;/a&gt;
+
 +
<br>
| width="269" valign="top" style="width:201.9pt;border-top:none;border-left: none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt; mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid windowtext .5pt; mso-border-alt:solid windowtext .5pt;padding:0cm 5.4pt 0cm 5.4pt" |  
| width="269" valign="top" style="width:201.9pt;border-top:none;border-left: none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt; mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid windowtext .5pt; mso-border-alt:solid windowtext .5pt;padding:0cm 5.4pt 0cm 5.4pt" |  
-
&lt;o:p&gt;&nbsp;&lt;/o:p&gt;
+
&lt;o:p&gt;&nbsp;&lt;/o:p&gt;  
|- style="mso-yfti-irow:88"
|- style="mso-yfti-irow:88"
Regel 890: Regel 892:
&lt;a  
&lt;a  
-
href="http://www.nvhb.nl/richtlijnhiv/extensions/FCKeditor/fckeditor/editor/17.5.%20Vaccinatie%20bij%20HIV-ge%C3%AFnfecteerde%20reizigers"&gt;17.5.  
+
href="http://www.nvhb.nl/richtlijnhiv/extensions/FCKeditor/fckeditor/editor/17.5.%20Vaccinatie%20bij%20HIV-ge%C3%AFnfecteerde%20reizigers"&gt;17.5. Vaccinatie bij <span class="SpellE">HIV-geïnfecteerde</span><span class="SpellE">reizigers</span>&lt;/a&gt;  
-
Vaccinatie bij <span class="SpellE">HIV-geïnfecteerde</span><span class="SpellE">reizigers</span>&lt;/a&gt;
+
 +
<br>
| width="269" valign="top" style="width:201.9pt;border-top:none;border-left: none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt; mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid windowtext .5pt; mso-border-alt:solid windowtext .5pt;padding:0cm 5.4pt 0cm 5.4pt" |  
| width="269" valign="top" style="width:201.9pt;border-top:none;border-left: none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt; mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid windowtext .5pt; mso-border-alt:solid windowtext .5pt;padding:0cm 5.4pt 0cm 5.4pt" |  
-
LCR
+
LCR  
-
CDC
+
CDC  
|- style="mso-yfti-irow:89"
|- style="mso-yfti-irow:89"
| width="350" valign="top" style="width:262.5pt;border:solid windowtext 1.0pt; border-top:none;mso-border-top-alt:solid windowtext .5pt;mso-border-alt:solid windowtext .5pt; padding:0cm 5.4pt 0cm 5.4pt" |  
| width="350" valign="top" style="width:262.5pt;border:solid windowtext 1.0pt; border-top:none;mso-border-top-alt:solid windowtext .5pt;mso-border-alt:solid windowtext .5pt; padding:0cm 5.4pt 0cm 5.4pt" |  
-
&lt;a href="http://www.nvhb.nl/richtlijnhiv/extensions/FCKeditor/fckeditor/editor/Bureau%27s%20voor%20reizigersadvisering"&gt;<span class="SpellE">Bureau's</span> voor reizigersadvisering&lt;/a&gt;
+
&lt;a href="http://www.nvhb.nl/richtlijnhiv/extensions/FCKeditor/fckeditor/editor/Bureau%27s%20voor%20reizigersadvisering"&gt;<span class="SpellE">Bureau's</span> voor reizigersadvisering&lt;/a&gt;  
| width="269" valign="top" style="width:201.9pt;border-top:none;border-left: none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt; mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid windowtext .5pt; mso-border-alt:solid windowtext .5pt;padding:0cm 5.4pt 0cm 5.4pt" |  
| width="269" valign="top" style="width:201.9pt;border-top:none;border-left: none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt; mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid windowtext .5pt; mso-border-alt:solid windowtext .5pt;padding:0cm 5.4pt 0cm 5.4pt" |  
-
&lt;o:p&gt;&nbsp;&lt;/o:p&gt;
+
&lt;o:p&gt;&nbsp;&lt;/o:p&gt;  
|- style="mso-yfti-irow:90"
|- style="mso-yfti-irow:90"
| width="350" valign="top" style="width:262.5pt;border:solid windowtext 1.0pt; border-top:none;mso-border-top-alt:solid windowtext .5pt;mso-border-alt:solid windowtext .5pt; padding:0cm 5.4pt 0cm 5.4pt" |  
| width="350" valign="top" style="width:262.5pt;border:solid windowtext 1.0pt; border-top:none;mso-border-top-alt:solid windowtext .5pt;mso-border-alt:solid windowtext .5pt; padding:0cm 5.4pt 0cm 5.4pt" |  
-
'''&lt;o:p&gt;&nbsp;&lt;/o:p&gt;'''
+
'''&lt;o:p&gt;&nbsp;&lt;/o:p&gt;'''  
| width="269" valign="top" style="width:201.9pt;border-top:none;border-left: none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt; mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid windowtext .5pt; mso-border-alt:solid windowtext .5pt;padding:0cm 5.4pt 0cm 5.4pt" |  
| width="269" valign="top" style="width:201.9pt;border-top:none;border-left: none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt; mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid windowtext .5pt; mso-border-alt:solid windowtext .5pt;padding:0cm 5.4pt 0cm 5.4pt" |  
-
<span style="mso-bidi-font-weight:bold">&lt;o:p&gt;&nbsp;&lt;/o:p&gt;</span>
+
<span style="mso-bidi-font-weight:bold">&lt;o:p&gt;&nbsp;&lt;/o:p&gt;</span>  
|- style="mso-yfti-irow:91;mso-yfti-lastrow:yes"
|- style="mso-yfti-irow:91;mso-yfti-lastrow:yes"
| width="350" valign="top" style="width:262.5pt;border:solid windowtext 1.0pt; border-top:none;mso-border-top-alt:solid windowtext .5pt;mso-border-alt:solid windowtext .5pt; padding:0cm 5.4pt 0cm 5.4pt" |  
| width="350" valign="top" style="width:262.5pt;border:solid windowtext 1.0pt; border-top:none;mso-border-top-alt:solid windowtext .5pt;mso-border-alt:solid windowtext .5pt; padding:0cm 5.4pt 0cm 5.4pt" |  
-
'''&lt;a'''
+
'''&lt;a'''  
-
'''href="http://www.nvhb.nl/richtlijnhiv/extensions/FCKeditor/fckeditor/editor/Hoofdstuk%2018.%20Kostenoverzicht%20antiretrovirale%20middelen"&gt;Hoofdstuk'''
+
'''href="http://www.nvhb.nl/richtlijnhiv/extensions/FCKeditor/fckeditor/editor/Hoofdstuk%2018.%20Kostenoverzicht%20antiretrovirale%20middelen"&gt;Hoofdstuk''' '''18. Kostenoverzicht antiretrovirale middelen&lt;/a&gt;'''  
-
'''18. Kostenoverzicht antiretrovirale middelen&lt;/a&gt;'''
+
 +
<br>
| width="269" valign="top" style="width:201.9pt;border-top:none;border-left: none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt; mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid windowtext .5pt; mso-border-alt:solid windowtext .5pt;padding:0cm 5.4pt 0cm 5.4pt" |  
| width="269" valign="top" style="width:201.9pt;border-top:none;border-left: none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt; mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid windowtext .5pt; mso-border-alt:solid windowtext .5pt;padding:0cm 5.4pt 0cm 5.4pt" |  
-
<span style="mso-bidi-font-weight:bold">&lt;o:p&gt;&nbsp;&lt;/o:p&gt;</span>
+
<span style="mso-bidi-font-weight:bold">&lt;o:p&gt;&nbsp;&lt;/o:p&gt;</span>  
|}
|}
-
&lt;o:p&gt;&nbsp;&lt;/o:p&gt;
+
&lt;o:p&gt;&nbsp;&lt;/o:p&gt;  
-
</div>
+
</div>  
&lt;/body&gt;&lt;/html&gt;
&lt;/body&gt;&lt;/html&gt;

Versie op 9 dec 2011 14:19

In onderstaande tabel staan verwijzingen naar andere richtlijnen opgesomd:


Pagina

Verwijzing naar andere richtlijnen<o:p></o:p>

<a

href="http://www.nvhb.nl/richtlijnhiv/extensions/FCKeditor/fckeditor/editor/Richtlijn%20HIV">Hoofdpagina (=inhoudsopgave)</a><o:p></o:p>


<o:p> </o:p>

<o:p> </o:p>

<o:p> </o:p>

<a

href="http://www.nvhb.nl/richtlijnhiv/extensions/FCKeditor/fckeditor/editor/Hoofdstuk%201.%20Achtergrondinformatie%20bij%20de%20ontwikkeling%20en%20herziening%20van%20deze%20richtlijn%20en%20inleiding">Hoofdstuk 1. Achtergrondinformatie bij de ontwikkeling en herziening van deze richtlijn en inleiding</a><o:p></o:p>


NVHB Richtlijn 2007<o:p></o:p>

<a

href="http://www.nvhb.nl/richtlijnhiv/extensions/FCKeditor/fckeditor/editor/Procedure%20herziening">Procedure herziening</a>


NVHB Richtlijn 2007

<a

href="http://www.nvhb.nl/richtlijnhiv/extensions/FCKeditor/fckeditor/editor/Samenstelling%20kernwerkgroep">Samenstelling kernwerkgroep</a>


<o:p> </o:p>

<a

href="http://www.nvhb.nl/richtlijnhiv/extensions/FCKeditor/fckeditor/editor/Overzicht%20belangen%20werkgroepleden">Overzicht belangen werkgroepleden</a>


<o:p> </o:p>

<a href="http://www.nvhb.nl/richtlijnhiv/extensions/FCKeditor/fckeditor/editor/Definities">Definities</a>

<o:p> </o:p>

Geschiedenis per pagina van deze richtlijn (= huidige pagina)

<o:p> </o:p>

<o:p> </o:p>

<o:p> </o:p>

<a

href="http://www.nvhb.nl/richtlijnhiv/extensions/FCKeditor/fckeditor/editor/Hoofdstuk%202.%20Therapie%20bij%20volwassenen">Hoofdstuk 2. Therapie bij volwassenen</a><o:p></o:p>


<o:p> </o:p>

<a

href="http://www.nvhb.nl/richtlijnhiv/extensions/FCKeditor/fckeditor/editor/2.1.%20Wanneer%20beginnen?">2.1. Wanneer beginnen?</a>


<o:p> </o:p>

<a

href="http://www.nvhb.nl/richtlijnhiv/extensions/FCKeditor/fckeditor/editor/Onderbouwing%20wanneer%20starten">Onderbouwing wanneer starten</a>


Aidsinfo NIH

<a

href="http://www.nvhb.nl/richtlijnhiv/extensions/FCKeditor/fckeditor/editor/Literatuur%202.1">Literatuur 2.1</a>


<o:p> </o:p>

<a

href="http://www.nvhb.nl/richtlijnhiv/extensions/FCKeditor/fckeditor/editor/2.2.%20Keuze%20van%20antiretrovirale%20therapie%20bij%20na%C3%AFeve%20volwassen%20pati%C3%ABnten">2.2. Keuze van antiretrovirale therapie bij naïeve volwassen patiënten</a>


Aidsinfo NIH

<a

href="http://www.nvhb.nl/richtlijnhiv/extensions/FCKeditor/fckeditor/editor/Literatuur%202.2">Literatuur 2.2</a>


<o:p> </o:p>

<a

href="http://www.nvhb.nl/richtlijnhiv/extensions/FCKeditor/fckeditor/editor/2.3.%20Tijdelijk%20onderbreken%20van%20HAART">2.3. Tijdelijk onderbreken van HAART</a>


Aidsinfo NIH

<a

href="http://www.nvhb.nl/richtlijnhiv/extensions/FCKeditor/fckeditor/editor/T%C2%BD%20van%20antiretrovirale%20middelen">T½ van antiretrovirale middelen</a>


<o:p> </o:p>

<a

href="http://www.nvhb.nl/richtlijnhiv/extensions/FCKeditor/fckeditor/editor/2.4.%20Richtlijn%20anti-retrovirale%20therapie%20bij%20voorbehandelde%20pati%C3%ABnten">2.4. Richtlijn anti-retrovirale therapie bij voorbehandelde patiënten</a>


Aidsinfo NIH

<o:p> </o:p>

<o:p> </o:p>

<a

href="http://www.nvhb.nl/richtlijnhiv/extensions/FCKeditor/fckeditor/editor/Hoofdstuk%203.%20Behandeling%20van%20HIV-1%20infectie%20bij%20kinderen">Hoofdstuk 3. Behandeling van HIV-1 infectie bij kinderen</a><o:p></o:p>


Penta<o:p></o:p>

Aidsinfo NIH<o:p></o:p>

<o:p> </o:p>

<o:p> </o:p>

<a

href="http://www.nvhb.nl/richtlijnhiv/extensions/FCKeditor/fckeditor/editor/Hoofdstuk%204.%20Monitoring">Hoofdstuk 4. Monitoring</a><o:p></o:p>


<o:p> </o:p>

<a

href="http://www.nvhb.nl/richtlijnhiv/extensions/FCKeditor/fckeditor/editor/4.1.%20Controles%20HIV-pati%C3%ABnten%20%28polikliniek%29">4.1. Controles HIV-patiënten (polikliniek)</a>


<o:p> </o:p>

<a

href="http://www.nvhb.nl/richtlijnhiv/extensions/FCKeditor/fckeditor/editor/Bij%20eerste%20consult%20bij%20HIV-seropositieve%20pati%C3%ABnt%20%28polikliniek%29">Bij eerste consult bij HIV-seropositieve patiënt (polikliniek)</a><a href="http://www.nvhb.nl/richtlijnhiv/extensions/FCKeditor/fckeditor/editor/Bij%20instellen%20op%20antiretrovirale%20therapie%20%28polikliniek%29" _fcknotitle=true _fcksavedurl="Bij instellen op antiretrovirale therapie (polikliniek)">Bij instellen op antiretrovirale therapie (polikliniek)</a>


<o:p> </o:p>

<a

href="http://www.nvhb.nl/richtlijnhiv/extensions/FCKeditor/fckeditor/editor/Eerste%20controle%20na%20instellen%20op%20anti-retrovirale%20therapie%204-6%20weken%20na%20start%20%28polikliniek%29">Eerste controle na instellen op anti-retrovirale therapie 4-6 weken na start (polikliniek)</a>


<o:p> </o:p>

<a

href="http://www.nvhb.nl/richtlijnhiv/extensions/FCKeditor/fckeditor/editor/Controle%20van%20pati%C3%ABnten%20op%20antiretrovirale%20therapie%20%28polikliniek%29">Controle van patiënten op antiretrovirale therapie (polikliniek)</a>


<o:p> </o:p>

<a

href="http://www.nvhb.nl/richtlijnhiv/extensions/FCKeditor/fckeditor/editor/Controle%20van%20pati%C3%ABnten%20zonder%20antiretrovirale%20therapie%20%28polikliniek%29">Controle van patiënten zonder antiretrovirale therapie (polikliniek)</a>


<o:p> </o:p>

<a

href="http://www.nvhb.nl/richtlijnhiv/extensions/FCKeditor/fckeditor/editor/4.2.%20Spiegelbepaling">4.2. Spiegelbepaling</a>


<o:p> </o:p>

<a

href="http://www.nvhb.nl/richtlijnhiv/extensions/FCKeditor/fckeditor/editor/4.3.%20Resistentiebepalingen">4.3. Resistentiebepalingen</a>


<o:p> </o:p>

<o:p> </o:p>

<o:p> </o:p>

<a

href="http://www.nvhb.nl/richtlijnhiv/extensions/FCKeditor/fckeditor/editor/Hoofdstuk%205.%20Diagnostiek%20en%20behandeling%20primaire%20HIV-infectie">Hoofdstuk 5. Diagnostiek en behandeling primaire HIV-infectie</a><o:p></o:p>


Aidsinfo NIH<o:p></o:p>

<o:p> </o:p>

<o:p> </o:p>

<a

href="http://www.nvhb.nl/richtlijnhiv/extensions/FCKeditor/fckeditor/editor/Hoofdstuk%206.%20Therapietrouw%20bevorderende%20maatregelen">Hoofdstuk 6. Therapietrouw bevorderende maatregelen</a><o:p></o:p>


<o:p> </o:p>

<a

href="http://www.nvhb.nl/richtlijnhiv/extensions/FCKeditor/fckeditor/editor/6.1.%20Therapietrouw%20be%C3%AFnvloedende%20factoren">6.1. Therapietrouw beïnvloedende factoren</a>


<o:p> </o:p>

<a

href="http://www.nvhb.nl/richtlijnhiv/extensions/FCKeditor/fckeditor/editor/Literatuur%206.1">Literatuur 6.1</a>


<o:p> </o:p>

<a

href="http://www.nvhb.nl/richtlijnhiv/extensions/FCKeditor/fckeditor/editor/6.2.%20Therapietrouw%20bevorderende%20interventies">6.2. Therapietrouw bevorderende interventies</a>


<o:p> </o:p>

<a

href="http://www.nvhb.nl/richtlijnhiv/extensions/FCKeditor/fckeditor/editor/Onderbouwing%20therapietrouw%20bevorderende%20interventies">Onderbouwing therapietrouw bevorderende interventies</a>


<o:p> </o:p>

<a

href="http://www.nvhb.nl/richtlijnhiv/extensions/FCKeditor/fckeditor/editor/Literatuur%206.2">Literatuur 6.2</a>


<o:p> </o:p>

<o:p> </o:p>

<o:p> </o:p>

<a

href="http://www.nvhb.nl/richtlijnhiv/extensions/FCKeditor/fckeditor/editor/Hoofdstuk%207.%20Preventie%20van%20moeder-kind%20overdracht:%20zwangerschap,%20bevalling%20en%20neonatale%20periode">Hoofdstuk 7. Preventie van moeder-kind overdracht: zwangerschap, bevalling en neonatale periode</a><o:p></o:p>


Aidsinfo NIH Perinatal<o:p></o:p>

NVHB Richtlijn 2007<o:p></o:p>

<a

href="http://www.nvhb.nl/richtlijnhiv/extensions/FCKeditor/fckeditor/editor/Literatuur%207">Literatuur 7</a>


<o:p> </o:p>

<o:p> </o:p>

<o:p> </o:p>

<a

href="http://www.nvhb.nl/richtlijnhiv/extensions/FCKeditor/fckeditor/editor/Hoofdstuk%208.%20HIV-2%20bij%20volwassenen:%20Behandeling%20en%20monitoring">Hoofdstuk 8. HIV-2 bij volwassenen: Behandeling en monitoring</a><o:p></o:p>


Aidsinfo NIH<o:p></o:p>

<a

href="http://www.nvhb.nl/richtlijnhiv/extensions/FCKeditor/fckeditor/editor/Literatuur%208">Literatuur 8</a>


<o:p> </o:p>

<o:p> </o:p>

<o:p> </o:p>

<a

href="http://www.nvhb.nl/richtlijnhiv/extensions/FCKeditor/fckeditor/editor/Hoofdstuk%209.%20Bijzondere%20omstandigheden">Hoofdstuk 9. Bijzondere omstandigheden</a><o:p></o:p>


<o:p> </o:p>

<a

href="http://www.nvhb.nl/richtlijnhiv/extensions/FCKeditor/fckeditor/editor/9.1.%20Adviezen%20m.b.t.%20inname%20van%20anti-HIV%20middelen%20na%20braken">9.1. Adviezen m.b.t. inname van anti-HIV middelen na braken</a>


<o:p> </o:p>

<a

href="http://www.nvhb.nl/richtlijnhiv/extensions/FCKeditor/fckeditor/editor/9.2.%20Adviezen%20m.b.t.%20inname%20van%20anti-HIV%20middelen%20bij%20vergeten%20van%20slikmoment">9.2. Adviezen m.b.t. inname van anti-HIV middelen bij vergeten van slikmoment</a>


<o:p> </o:p>

<a

href="http://www.nvhb.nl/richtlijnhiv/extensions/FCKeditor/fckeditor/editor/9.3.%20Marge%20tussen%20twee%20innames">9.3. Marge tussen twee innames</a>


<o:p> </o:p>

<a

href="http://www.nvhb.nl/richtlijnhiv/extensions/FCKeditor/fckeditor/editor/9.4.%20Inname%20medicatie%20bij%20overschrijden%20tijdzones">9.4. Inname medicatie bij overschrijden tijdzones</a>


<o:p> </o:p>

<a

href="http://www.nvhb.nl/richtlijnhiv/extensions/FCKeditor/fckeditor/editor/9.5.%20Adviezen%20m.b.t.%20gebruik%20anti-HIV%20middelen%20door%20de%20sonde">9.5. Adviezen m.b.t. gebruik anti-HIV middelen door de sonde</a>


<o:p> </o:p>

<a

href="http://www.nvhb.nl/richtlijnhiv/extensions/FCKeditor/fckeditor/editor/9.6.%20Doseringen%20bij%20gestoorde%20lever-%20en%20nierfunctie">9.6. Doseringen bij gestoorde lever- en nierfunctie</a>


<o:p> </o:p>

<o:p> </o:p>

<o:p> </o:p>

<a

href="http://www.nvhb.nl/richtlijnhiv/extensions/FCKeditor/fckeditor/editor/Hoofdstuk%2010.%20Behandeling%20van%20hepatitis%20B/C-virus%20co%C3%AFnfectie%20bij%20HIV-1%20positieve%20pati%C3%ABnten">Hoofdstuk 10. Behandeling van hepatitis B/C-virus coïnfectie bij HIV-1 positieve patiënten</a><o:p></o:p>


<o:p> </o:p>

<a href="http://www.nvhb.nl/richtlijnhiv/extensions/FCKeditor/fckeditor/editor/10.1.%20Hepatitis%20B">10.1. Hepatitis B</a><o:p></o:p>

EACS

<a href="http://www.nvhb.nl/richtlijnhiv/extensions/FCKeditor/fckeditor/editor/10.2.%20Hepatitis%20C%C2%A0%28acuut%29">10.2. Hepatitis C (acuut)</a><o:p></o:p>

NL aanbevelingen

NEAT

<a href="http://www.nvhb.nl/richtlijnhiv/extensions/FCKeditor/fckeditor/editor/Levels%20of%20evidence">Levels of evidence</a><o:p></o:p>

<o:p> </o:p>

<a

href="http://www.nvhb.nl/richtlijnhiv/extensions/FCKeditor/fckeditor/editor/Literatuur%2010.2">Literatuur 10.2</a>


<o:p> </o:p>

<a

href="http://www.nvhb.nl/richtlijnhiv/extensions/FCKeditor/fckeditor/editor/10.3.%20Hepatitis%20C%C2%A0%28chronisch%29">10.3. Hepatitis C (chronisch)</a>


EACS

<o:p> </o:p>

<o:p> </o:p>

<a

href="http://www.nvhb.nl/richtlijnhiv/extensions/FCKeditor/fckeditor/editor/Hoofdstuk%2011.%20Behandeling%20van%20tuberculose%20bij%20pati%C3%ABnten%20met%20een%20HIV-infectie">Hoofdstuk 11. Behandeling van tuberculose bij patiënten met een HIV-infectie</a><o:p></o:p>


CBO Tuberculose-HIV<o:p></o:p>

<a

href="http://www.nvhb.nl/richtlijnhiv/extensions/FCKeditor/fckeditor/editor/Literatuur%2011">Literatuur 11</a>


<o:p> </o:p>

<o:p> </o:p>

<o:p> </o:p>

<a

href="http://www.nvhb.nl/richtlijnhiv/extensions/FCKeditor/fckeditor/editor/Hoofdstuk%2012.%20Comorbiditeit%20en%20bijwerkingen">Hoofdstuk 12. Comorbiditeit en bijwerkingen</a><o:p></o:p>


EACS<o:p></o:p>

<o:p> </o:p>

<o:p> </o:p>

<a

href="http://www.nvhb.nl/richtlijnhiv/extensions/FCKeditor/fckeditor/editor/Hoofdstuk%2013.%20Screening%20van%20HIV-pati%C3%ABnten%20op%20anogenitale%20maligniteiten">Hoofdstuk 13. Screening van HIV-patiënten op anogenitale maligniteiten</a><o:p></o:p>


<o:p> </o:p>

<a

href="http://www.nvhb.nl/richtlijnhiv/extensions/FCKeditor/fckeditor/editor/Onderbouwing%20screening%20van%20HIV-pati%C3%ABnten%20op%20anogenitale%20maligniteiten">Onderbouwing screening van HIV-patiënten op anogenitale maligniteiten</a>


<o:p> </o:p>

<a

href="http://www.nvhb.nl/richtlijnhiv/extensions/FCKeditor/fckeditor/editor/Literatuur%2013">Literatuur 13</a>


<o:p> </o:p>

<o:p> </o:p>

<o:p> </o:p>

<a

href="http://www.nvhb.nl/richtlijnhiv/extensions/FCKeditor/fckeditor/editor/Hoofdstuk%2014.%20Interacties">Hoofdstuk 14. Interacties</a><o:p></o:p>


<o:p> </o:p>

<o:p> </o:p>

<o:p> </o:p>

<a

href="http://www.nvhb.nl/richtlijnhiv/extensions/FCKeditor/fckeditor/editor/Hoofdstuk%2015.%20Profylaxe%20en%20behandeling%20van%20opportunistische%20infectie">Hoofdstuk 15. Profylaxe en behandeling van opportunistische infectie</a><o:p></o:p>


CDC<o:p></o:p>

Nationale antibioticaboekje<o:p></o:p>

<o:p> </o:p>

<o:p> </o:p>

Hoofdstuk 16. Post Exposure Profylaxe na prikaccident en onveilig sexueel contact

<o:p> </o:p>

<a

href="http://www.nvhb.nl/richtlijnhiv/extensions/FCKeditor/fckeditor/editor/Hoofdstuk%2016.%20Transmissiereductie%20%28PEP%29">Hoofdstuk 16. Transmissiereductie (PEP)</a><o:p></o:p>


<o:p> </o:p>

<a

href="http://www.nvhb.nl/richtlijnhiv/extensions/FCKeditor/fckeditor/editor/16.1.%20Prikaccidenten">16.1. Prikaccidenten</a>


LCI

<a

href="http://www.nvhb.nl/richtlijnhiv/extensions/FCKeditor/fckeditor/editor/16.2.%20Seksaccidenten">16.2. Seksaccidenten</a>


LCI/RIVM

<o:p> </o:p>

<o:p> </o:p>

<a

href="http://www.nvhb.nl/richtlijnhiv/extensions/FCKeditor/fckeditor/editor/Hoofdstuk%2017.%20Vaccinatiebeleid">Hoofdstuk 17. Vaccinatiebeleid</a><o:p></o:p>


<o:p> </o:p>

<a

href="http://www.nvhb.nl/richtlijnhiv/extensions/FCKeditor/fckeditor/editor/17.1.%20Vaccinaties%20bij%20HIV-ge%C3%AFnfecteerde%20kinderen">17.1. Vaccinaties bij HIV-geïnfecteerde kinderen</a>


CDC

<a

href="http://www.nvhb.nl/richtlijnhiv/extensions/FCKeditor/fckeditor/editor/17.2.%20Vaccinatie%20tegen%20influenza">17.2. Vaccinatie tegen influenza</a>


NHG Standaard

<a

href="http://www.nvhb.nl/richtlijnhiv/extensions/FCKeditor/fckeditor/editor/Onderbouwing%20Vaccinatie%20tegen%20influenza">Onderbouwing Vaccinatie tegen influenza</a>


<o:p> </o:p>

<a

href="http://www.nvhb.nl/richtlijnhiv/extensions/FCKeditor/fckeditor/editor/Literatuur%2017.2">Literatuur 17.2</a>


<o:p> </o:p>

<a

href="http://www.nvhb.nl/richtlijnhiv/extensions/FCKeditor/fckeditor/editor/17.3.%20Vaccinatie%20tegen%20infecties%20met%20Streptococcus%20pneumoniae%20%28Pneumokokken%29">17.3. Vaccinatie tegen infecties met Streptococcus pneumoniae (Pneumokokken)</a>


<o:p> </o:p>

<a

href="http://www.nvhb.nl/richtlijnhiv/extensions/FCKeditor/fckeditor/editor/Onderbouwing%20Vaccinatie%20tegen%20infecties%20met%20Streptococcus%20pneumoniae%20%28Pneumokokken%29%20%28Pneumokokken%29">Onderbouwing Vaccinatie tegen infecties met Streptococcus pneumoniae (Pneumokokken) (Pneumokokken)</a>


<o:p> </o:p>

<a

href="http://www.nvhb.nl/richtlijnhiv/extensions/FCKeditor/fckeditor/editor/Literatuur%2017.3">Literatuur 17.3</a>


<o:p> </o:p>

<a

href="http://www.nvhb.nl/richtlijnhiv/extensions/FCKeditor/fckeditor/editor/17.4.%20Vaccinaties%20tegen%20Hepatitis%20A%20en%20B">17.4. Vaccinaties tegen Hepatitis A en B</a>


<o:p> </o:p>

<a

href="http://www.nvhb.nl/richtlijnhiv/extensions/FCKeditor/fckeditor/editor/17.5.%20Vaccinatie%20bij%20HIV-ge%C3%AFnfecteerde%20reizigers">17.5. Vaccinatie bij HIV-geïnfecteerdereizigers</a>


LCR

CDC

<a href="http://www.nvhb.nl/richtlijnhiv/extensions/FCKeditor/fckeditor/editor/Bureau%27s%20voor%20reizigersadvisering">Bureau's voor reizigersadvisering</a>

<o:p> </o:p>

<o:p> </o:p>

<o:p> </o:p>

<a

href="http://www.nvhb.nl/richtlijnhiv/extensions/FCKeditor/fckeditor/editor/Hoofdstuk%2018.%20Kostenoverzicht%20antiretrovirale%20middelen">Hoofdstuk 18. Kostenoverzicht antiretrovirale middelen</a>


<o:p> </o:p>

<o:p> </o:p> </div> </body></html>